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Summary
This thesis describes the attempted syntheses of polyamine based peptide 
toxins (enzymatically) and of 5-mono and 5,8-disubstituted indolizidines (by 
conventional chemical methods).
Chapter 2 describes the construction of the 5,6 bicyclic skeleton of the 
indolizidine alkaloids. This was achieved by utilizing L-glutamic acid 
dimethyl ester to form the N-pyrrolo derivative [224], cyclization to the 
bicyclic compound [214], achieved using acid equivalents, as well as the 
hydrogenation of [214] to either the alcohol [215] or the fully reduced 
compound [263] depending on choice of catalyst and pH. Investigations were 
carried out into the mechanism of hydrogenation of [214] by the attempted 
synthesis of postulated intermediates [281] and [282]. The results of these 
syntheses and the submission of the products to our hydrogenation 
conditions are discussed.
' /
Chapter 3 describes the attempted syntheses of 5-monosubstituted 
indolizidines from [263] and 5,8-disubstituted indolizidines from [215]. This 
was undertaken by the activation of the 8-hydroxyl group in [215] and of the 
alcohol group derived from the ester of [263], followed by attempted 
substitution. Problems were encountered in both the activation and 
substitution reactions and these are rationalized in terms of the position of 
both the alcohol groups p to the nitrogen of the indolizidine skeleton.
Chapter 4 describes attempts towards the differentiation of the two termini of 
spermidine by various enzymes. The methodology was tested by the chemical 
protection of the amine functions and attempted enzymatic hydrolysis. The 
protecting groups chosen were acetyl (Ac) and benzyloxycarbonyl (Cbz) 
yielding the 1,4-diaminobutane derivatives [378] and [379] and the spermidine 
derivatives [380] and [381]. The failure of the enzymatic hydrolyses of these 
compounds is discussed.
xi
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1.1 What is a natural product ?
A natural product is a naturally occurring organic molecule. This 
definition takes us from relatively simple amino acids to large, complex 
enzymes such as chymotrypsin. Usually natural products are metabolites, 
either primary or secondary (Figure l 1). The term 'primary metabolite' refers 
to the products of photosynthetic processes which produce the carboxylic acids 
(aliphatic amino acids) of the Krebs cycle. These go on to be incorporated into 
proteins, carbohydrates which form the polysaccharides, fats, nucleotides and 
the polymers derived from them (DNA, RNA) and proteins, i.e. The primary 
components of the cell and the major players in the dynamic processes of life.
The secondary metabolites (phenolics, terpenoids, steroids and 
alkaloids) are of limited occurrence and are often characteristic of a particular 
biological group (family or genus). They are often thought of as waste 
products, as their function is principally unknown and the organisms can 
function perfectly well without them (as proved by grafting experiments on 
plants). These compounds may not be vital for life but, as will be shown, they 
may play important roles in prolonging life (for example by making the 
organism distasteful) and perhaps increasing the quality of life (e.g. making a 
mate easier to find).
Indeed, it seems nonsensical to assume that organisms should allocate 
a large proportion of metabolic resources to the production of compounds 
which have no use. For example, the ladybird produces the human 
equivalent of 1.5 kg of the tricyclic N-oxide [ l ] , 2 and the honey bee has 
developed a pheromone gland, the Nassanov gland, for the release of 
geraniol [2].
2
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Figure 1. Metabolic production of Natural Products.1
1.2 Secondary m etabolites as 
chemicals'.
'e ffect
Secondary metabolites are 'effect chemicals',3 viz. compounds that 
cause a biological effect. However, in the case of most secondary metabolites 
we have yet to discover the effect, if indeed there is one. Secondary
metabolites from plants and animals can exert strong behaviour control both 
on members of the same species and of other species. Several areas of 
chemical control have been proposed:4
1.2.1 Semiochemicals.
Semiochemicals are defined as 'signaling chemicals that carry messages 
between individuals of the same species'. The messages that these chemicals 
transmit vary from information as to the position of a food source to sexual 
attraction. Examples of pheromones used in sexual attraction include the 
relatively simple moth and beetle pheromones [3], [4] to more complex 
terpenoids from the same organisms [5], [6].
The area of chemical sexual attractants is not limited to insects. 
Androstenone [7] is a putative human pheromone which is mainly produced 
by males, though females secrete the steroid to a lesser extent. Indeed, a study 
by McClintock5 showed that among women, the higher secretors in an all 
female dormitory produced synchronous menstrual cycles in the lower
4
secreting women (synchronous with the higher secretor) to such an extent 
that all the women in the dormitory attained oestrus at the same time.
Androstenone is also secreted by male pigs (and truffles, hence the use 
of sows to dig truffles), a reason why boar meat is not on sale in shops (due to 
its unpleasant smell upon cooking). Androstenone is also used in aerosol 
form to arouse sows as well as in certain types of aftershave which are 
reported to increase sex appeal. There are also age-old links between 
secondary metabolites and sexual arousal. Humans have daubed themselves 
with the secretions of the penile sheath of the musk deer, containing 
muscone [8], those of the scent glands of the civet cat, containing civetone [9], 
secretions from sperm whales (ambergris [10]) and the odours of various 
flowers and spices in the complex mixtures of today's perfumes to increase 
their attractiveness to the opposite sex.
5
o[ 10]
1.2.2 Feedants, antifeedants, repellents and toxins.
Many plants secrete chemicals that make them unpleasant to taste and 
sometimes even poisonous to the insects and higher organisms that feed on 
them. Warburganal [11] has been isolated6 from the East African tree 
Warburgia stuhlmannii and has been found to have an antifeedant effect 
upon the larvae of the army worm. However, such compounds do not have a 
universal effect. Warburganal has no effect on the locust and, in another 
example, the glycosinate sinigrin [12], though it repels most insects, is an 
attractant to the cabbage butterfly (Pieris brassicae).
Danus monarch butterflies have adapted to accumulate toxic cardenolides 
from food sources while caterpillars which repel birds from the adults.4 
Toxins are widespread in the natural world and many plants and animals 
produce these compounds. Two of these are batrachotoxin [13] from the skin 
of a Colombian frog and tetrodotoxin [14] from the Japanese puffer fish.
6
1.2.3 Defense and alarm.
Natural products secreted at the time of, or stored and released upon, 
attack in defense are many and varied as in the quinone [15] exuded by the 
millipede Nurceus gardanus or a mixture of simple benzoquinines projected 
by the bombadier beetle Brachyrus crepitons.7 The best known of these 
defenses is probably the mercaptan [16] released from the anal glands of the 
skunk when startled or attacked. The hyena also releases an anal exudate [17] 
under stress. Charles Butler noted in 1609 that bees could be attracted and 
enraged to sting by the presence of a single bee sting.3 We now know that this 
is in response to isoamyl acetate [18], an alarm pheromone released when a 
bee's abdomen is ripped (releasing the sting).
[15] [16]
7
oo
[17] [18]
1.2.4 Development and growth.
The steroid ecdysone [19] stimulates metamorphosis. The so-called 
juvenile hormone [20] exerts the opposite effect of preventing 
metamorphosis of insects and thus hampering the development into adults. 
These two compounds have obvious potential in cases where controlling the 
life cycle of an insect would be of use, for example in pesticides.
OH
OH
h o 4
HO’
[19]
[2q
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1.2.5 Social behaviour.
The 'social insects', viz. termites, some bees and wasps and the ants, are 
the greatest users of semiochemicals. The social organisation of their hives 
and nests means that the individuals have more need to communicate. The 
so-called queen substance [21] (9-oxo-2-decenoic acid) produced by the honey 
bee queen stabilises swarms, controls queen-cell building and attracts drones 
to mate. A whole series of semiochemicals have been found e.g. [22]-[26] 
which are used by ants to mark trails which lead fellow workers both to food 
sources and back to the nest.3
Bees use geraniol [2] as a marker pheromone to tag sources of food, water and 
the nest. Bark beetle pheromones are a mixture of compounds e.g. [27]-[29] 
that are aggregation pheromones for both sexes.8 These are of particular
9
interest in the treatment of Dutch elm disease which is carried by these 
beetles.
[ 27] [28] [29]
1.3 History of natural products.
1.3.1 Ancient history.
Natural products, and their sources have long fascinated man with 
their intriguing biological activities. The emperor Shen Nung recommended 
the laxative properties of rhubarb in his Pharmacopoeia (a? 2700 BC) and 
Homer and Virgil both mention the use of 'potions' derived from natural 
sources to treat illness and sometimes to induce it. Fragrances and spices, all 
of whose active ingredients are natural products have long been extolled. 
This is illustrated in the 'Song of Songs' from Ecclesiastics II,9 apparently 
written by King Solomon to the Queen of Sheba, showing the Israelites' 
fascination with natural products dating back to 1000 BC.
1.3.2 Modem history.
Scientists are still fascinated by the varied biological activities of natural 
products. John Ray in 1690 commented upon attraction of male moths to a 
caged female10 and today whole teams of scientists are engaged in the 
extraction, identification and testing of compounds from natural sources.
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The arena of natural products provides a range of synthetic targets 
unparalleled in any other area of chemistry. This is amply illustrated by 
looking at the alkaloids, which are the most structurally diverse class of 
secondary metabolites. Over 5000 compounds are known, ranging from the 
structurally simple histamine [30] to the complex structure of taxol [31]. Taxol, 
though a relatively small molecule, has eleven chiral centers.
Although many alkaloids were isolated and characterised decades ago, new 
and interesting alkaloids, some structurally related, others being the first 
members of new classes, are continuously being discovered in great numbers. 
Thus, the synthetic challenge goes on.
1.4 The need to synthesise natural products.
Nature has developed complex synthetic routes to primary and 
secondary metabolites. We could argue that with the use of the most 
structurally demanding and efficient catalysts known, viz. enzymes, nature 
will synthesise natural products better than us. We have alluded to the 
intellectual challenge in the previous section but there are other reasons.
The first synthesis of a natural product, viz. Wdhler's urea,11 was one 
of the important steps in refuting the doctrine of vitalism, i.e. the theological
11
idea of a 'mysterious force' pervading all living matter and differentiating it 
from non-living. This proved that compounds produced from living things 
were in no way different than those produced chemically in the lab. With our 
present knowledge of chemistry, biochemistry and biology we need no further 
proof that natural and 'unnatural' (produced in the lab) compounds are the 
same, with the same activity in biological systems. So this reason for natural 
product synthesis belongs to the past.
Over 60% of the world's population are estimated to use, at some point 
in their lives, medicinal chemicals derived from animal and plant sources. 
Over half of all U.S. prescriptions fall into this category. Most of the 
remaining half are synthetic compounds based on chemical modifications of 
natural substances. Approximately 120 drugs of known structure are still 
extracted from their natural sources for use. Opium, in use for at least 5000 
years, and cocaine, used for ca. 2000 years, would both fall into this category. 
Ancient Chinese herbalism has been the source of many of these drugs and, 
although the Chinese market consumes some of these, most of the 120 are 
used in western medicine.
As mentioned, many of the drugs on the market are analogues of 
natural products. Chemical modifications can produce new drugs with 
superior activity against the target illness. So, the synthesis of natural 
products is of great importance to provide 'lead' compounds, suggesting the 
functionality needed to achieve an active end product.
Secondary metabolites are not, as a rule, produced in large quantities. 
For example, spongistatin 1 [32], a potent antineoplastic agent isolated from 
the south west African marine sponge Spirastrella spinispirulifera, has 
recently been isolated. Just 1.8 mg was obtained from 2409 Kg of wet sponge.12
12
Taxol [31], isolated from the bark of the pacific yew in minor amounts,13 also 
it is only found in this species and in a specific geographic location. The 
pacific yew has a very slow growth rate. Thus to supply taxol for widespread 
clinical trials would mean the extinction of the species and no more natural 
taxol. So, the synthesis of natural products has yet another purpose. That is to 
provide pharmaceutically interesting compounds in quantities sufficient for 
evaluation of activity.
[32]
1.5 The desirable properties of a synthesis.
All syntheses have desirable properties, that isolation and separation of 
the product from starting materials and by-products is feasible, high yields, 
few synthetic steps etc. A number of these properties are particularly desirable 
in the synthesis of a natural product as the product is to be as close to that 
from the natural source as possible. Also of consideration is the use of the 
synthesised natural product as a lead compound for the synthesis of
13
analogues, and that enough be produced for practical purposes. In particular, 
we can identify two important considerations:
1.5.1 Enantiomeric purity of products.
Chirality, if this meant simply that two enantiomers rotated plane 
polarised light in equal and opposite directions would have little bearing on 
synthetic organic chemistry. However, enantiomers only have identical 
chemical and physical properties in the absence of an external chiral influence 
and this is where the problem becomes more complex. Life is chiral as most of 
the important building blocks of biological macromolecules are chiral e.g. 
amino acids and sugars.
If both enantiomers are active there is no guarantee that both will be
' t
equally active. Indeed, they may have entirely different effects. For example, 
(R)-penicillamine [33] is an antidote for lead and mercury poisoning whereas 
the enantiomer (S-)-penicillamine, causes the optic nerve to atrophy leading 
to blindness.
The American FDA (Federal Drug Administration) will not now allow 
the marketing of a racemate to humans unless the enantiomer which is not 
needed is proven to be inert and cause no side effects. It is possible that both 
enantiomers may have a favourable, though different, effect. The alkaloid (-)- 
levorphanol [34] is a powerful narcotic analgesic exhibiting an activity five to
14
six times that of morphine. Its enantiomer, (+)-dextrorphan [35], is a cough 
suppressant.
NMe r--NM e
HO' HO
[34] [35]
As a footnote to this discussion it should be stated that not all natural 
products are enantiomerically pure. For example the crude terpene a-pinene 
is actually a mixture of 92% [36] and 4% [37] when isolated from pine resin.
1.5.2 Analogue synthesis.
Often chemically closely related structures can have quite different 
properties. The methyl ether [38] has the distinctive raw potato odour, the 
branched ether [39] smells like green peppers and the methyl ketone [40] of 
popcorn.14
[36] [37]
O
[38] [39] [40]
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So, small structural modifications and functional group changes have 
a large effect on the physiological action of the some of these compounds. 
Some syntheses are designed to contain a late-stage common intermediate, 
one which can undergo a variety of reactions to produce a variety of related 
products and thus be of greater synthetic utility than a more linear approach. 
An example of this comes from Nukui et a/,15 who undertook the 
asymmetric Heck-type cyclization of [41] to give the unsaturated bicyclic 
compound [42], asymmetry being induced through a chiral palladium species 
in the presence of silver carbonate. From this they have achieved the 
synthesis of the related lentiginosine [43] and 1,2-dipilentiginosine [44] as well 
as the indolizidines [45] and [46] (Scheme 1). They propose that with further 
functionalisation many other related natural and unnatural products can be 
synthesised from this common core.
[43] [44] [45]
Scheme 1
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1.6 The Alkaloids
1.6.1 Introduction.
The alkaloids are probably the group of compounds which have been 
used more than any others in the pursuit of pleasure and as deadly poisons 
and sedatives. Examples of euphoriants, psychedelics and stimulants include 
morphine [47] from Papaver somtiiferum, cocaine [48] from Erythroxylon 
coca, lysergic acid [49] and derivatives, in Claviceps purpurea, and mescaline 
[50], in the indian peote cactus Lophophora williansii, used by the American 
indian shamen to ascend to the astral plane to communicate with their gods. 
The Mayan priesthood used the Mexican mushroom Psilocybe mexicana 
(containing psilocybin [51]) with the same goal.
Plant extracts have been used since ancient times to induce death and 
disability. Cleopatra, before deciding on the venom of the asp as the vehicle
17
for her own demise, conducted tests on slaves using henbane (Hycoscyamus 
niger), deadly nightshade (Atropa belladonna), and Strychnos nux vomica. 
All were quick but painful, Strychnos nux vomica having the added 
disadvantage of leaving the victim's face contorted in death. A tropa  
belladonna berries (containing atropine [52]) were used by Agrippina, wife of 
the Roman emperor Claudius, to murder him, the juice being injected into 
the fruit of his personal fig tree.
Hycosine [53], from the mandrake (Mandrogora officinium) was a 
favorite of the renaissance poisoner Cesare Borgia. Other plants of the 
Solenaceae family (which includes the tomato and the potato) contain 
hycosine [53] as a major constituent. This active ingredient has been utilised 
by many, for example by Dr. Crippen as a poison, by suckling Colombian 
mothers who smeared the extract on their nipples as an infanticide agent and 
by 16lh century Hindu prostitutes who used more dilute extracts to subdue 
their clients, thus curbing their carnal appetites.
Perhaps the most infamous death by alkaloid was that of Socrates. 
Coniine [54] from Conium maculatum was a commonly used poison for state 
executions and indeed Socrates’ death was induced with this drug. Modern 
medicine harnesses many of these tools of destruction. Atropine [52] is used 
in eye surgery, morphine [47] as a pain killer and reserpine [55] as a 
tranquilliser and many modem day drugs contain similar compounds.
18
The traditional definition of an alkaloid, first put forward by W. 
Meissner in 1879, encompassed "nitrogenous compounds of complex 
molecular structure and significant pharmacological activity confined to the 
plant kingdom". The isolation, in recent years, of alkaloids from insect, 
amphibian and even mammalian sources has rendered this classification 
obsolete. Pelletier's more recent definition, proposed in 1982, is, "cyclic 
nitrogen-containing molecules, which are true secondary metabolites". A 
further stipulation, that the nitrogen atom must have a negative oxidation 
state excludes nitro and nitroso compounds, though both these groups may be 
present in the side chains.
1.62  Classification of Alkaloids.
Most compounds covered by Pelletier's definition can be constructed 
from building blocks of the shikimic acid, polyketide or mevalonic acid 
pathways in conjunction with an amino acid which determines the character 
of the alkaloid and thus its classification. Ornithine [56] gives rise to, for 
example hygrine [57], retronecine [58] and nicotine [59]. Lysine [60] is the 
precursor to isopelletierine [61] and lupine [62] (Figure 2).
19
h o  r " OH
t s S
[58]
o $
[62]
Figure 2. Alkaloids derived from ornithine and lysine.
i
The aromatic amino adds phenylalanine [63] and tryptophan [64] give 
rise to alkaloids such as morphine [47] and strychnine [65] (Figure 3)1. There is 
also a class of 'pseudoalkaloids', those not derived from amino acids but from 
a polyketide or terpenoid, the nitrogen atom coming ultimately from 
ammonia. Coniine [54] is an example of a pseudoalkaloid.
Alkaloids from amphibian sources are structurally related to the 
pyrolizidines, quinolizidines and other piperidine-type alkaloids. These are 
derived from ornithine and lysine and will be discussed in Chapter 2. The 
other classes will not be discussed in any further depth as there are good 
reviews of their occurrence, biosynthesis and synthesis.1-4-14
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1
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2.1 Amphibian Alkaloids
In recent years, there has been much interest in the biological evaluation 
of the natural products found in the skin extracts of neotropical poison 
frogs.16 The skin extracts contain four major classes of compounds with a 
range of toxicitys, some merely noxious, some highly toxic. These are biogenic 
amines, peptides, bufodienolides (bufogenins) and alkaloids. There are more 
than 2 0 0  'dendrobatid' alkaloids, so-called as most are unique to the 
neotropical poison frogs of the genera D en drobates  and P hyllobates  
(D en drobatidae), of diverse structure and biological activity. These 
compounds can be divided into major and minor classes, these terms 
pertaining to the number of alkaloids in each class and/or ubiquity among 
the species. Some of the classes are named after the species from which they 
were first isolated. For example the pumiliotoxins A, B and C were isolated 
from the Panamanian frog D. pumilio and a Colombian frog, D. histrionicus 
afforded the histrionicotoxins.
The dendrobatid alkaloids are secreted in such small amounts that 
structural determination has required the sacrifice of many frogs. Even then, 
most of the structural determination was carried out using TLC and GC-MS 
on the alkaloid residues.17'18«19 Very few were isolated in sufficient amounts 
for NMR analysis. After TLC analysis and sometimes preparative TLC, GC 
analysis was undertaken in four steps. Firstly GC provided a quantitative 
profile of alkaloid components.18 This was followed by GC-NH3CIMS with 
computer assistance to provide the number, elution sequence and parent ions 
of the alkaloids present. Repetition of GC-CIMS using deuteroammonia 
showed the number of exchangeable hydrogens (OH and secondary amines).
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Finally GC-EIMS was carried out. Usually collation and analysis of this data 
allowed characterisation and identification of the individual alkaloids.
2.1.1 Batrachotoxins.
The batrachotoxin class contains few compounds but they are highly toxic 
steroidal alkaloids, such as Batrachotoxin A [13] occurring only in species 
phyllobates. They were the first of the dendrobatid alkaloids to be isolated and 
characterised .20-21 The six known batracotoxins occur in relatively large 
amounts in the skin extracts of the phyllobates family. P. terribilis secretes up 
to 800 pg per frog as a mixture of these.
2.1.2 Histrionicotoxins.
Histrionicotoxins, for example Histrionicotoxin A [6 6 ], were first isolated 
from D en drobates  h is tr io n icu s .22 These relatively  non-toxic 
azaspiro[5.5]undecanols have two exchangeable protons (OH and NH). The 16 
known examples differ in the length and degree of unsaturation in the two 
side chains. The stereochemistry of the alkene functionality is usually cis 
(where determined).
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2.1.3 Indolizidines.
The dendrobatid alkaloids include a large variety of indolizidines from the 
relatively simple mono-substituted 167B [67] to the complex gephyrotoxin 
289B [6 8 ]. Gephyrotoxins contain the indolizidine skeleton with additional 
functionality which characterises this class, though this is an older 
classification. Simple indolizidines, such as 195B [69], 223AB [70], 239AB [71], 
239CD [72], were originally classified as gephyrotoxins but are now referred to, 
as are all the dendrobatid alkaloids, by the system proposed by Daly et a/.18 
This system assigns all the dendrobatid alkaloids a number which is simply 
the molecular weight. If more than one alkaloid has the same molecular 
weight an identifying letter A, B etc. is assigned. For those with a close 
structural relationship prime and double prime designations are added to 
clarify this point. Indolizidines with the double letter designation e.g. 223AB 
[70] were originally assigned separate structures based on incorrect spectral
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assignments. 18 When the GC results were rationalised the double letter 
designation came into use16 to indicate both structures were in fact the same.
The indolizidine class may be subdivided into 3,5-disubstituted and 5,8- 
disubstituted indolizidines. The 3,5-disubstituted indolizidines were the first 
to be discovered, 195B [69], 223AB [70], 239AB [71], 239CD [72], being those 
isolated in sufficient quantities to be assigned unambiguously by NMR.19-23 A 
series of congeneric 8 -methylindolizidines, 203A[73], 205A[74], 207A [75], 209A 
[76] have been found, their structures differing only in the degree of 
unsaturation in the 5-carbon side chain.19'24 The dendrobatid alkaloids 
include many simple bicyclic alkaloids containing a tertiary nitrogen and 
usually a piperidine ring. Many of these are assumed to be indolizidines 
when the tentative structures are assigned. Indeed 207A [75], originally of 
unidentified structure17 was recently shown to be 5-(pent-5-enyl)-8-methyl 
indolizidine, the first of this 5,8-disubstituted class. There are many members 
of this class and all bicyclic tertiary amine alkaloids with a base peak at m/z 
138 are put in this class.
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2.1.4 Pumiliotoxin-A class.
Pumiliotoxin-A [77], was isolated in 1967 from the Panamanian frog 
Dendrobates pumilio,25 but the structure was not assigned until 1980.26 The 
pumiliotoxins could also be thought of as indolizidines, as they have the 
standard 5,6 bicyclic structure. The characteristic additional features of 
pumiliotoxins are a quaternary 8  position and an exocyclic double bond at C -6  
(e.g. 323A [77]). The allopumiliotoxins (e.g. 253A [78]) have an additional 
hydroxyl function at C-7 and homopumiliotoxin 223G [79] has, rather than 
the indolizidine skeleton, a quinolizidine ring system.
[77] [78] [79]
27
2.1.5 Decahydroquinolines
The older 'pumiliotoxin-C' class designation has been superseded by the 
term decahydroquinolines. Pumiliotoxin C 195A [80] was the first member of 
this class to be isolated .2 7  Interestingly, both c is  and t r a n s  
decahydroquinolines [80], [81] are known. They normally occur together with 
the histrionicotoxins in the species of dendrobates and phyllobates. This led to 
the postulation that they represent members of a deoxyhistrionicotoxin class, 
though with no proof.17
[80] * [81]
2.1.6 The minor alkaloids.
The seven 'minor' classes of dendrobatid alkaloids are referred to as such 
due either to limited variety within the class or limited taxonomic 
distribution. They normally occur as trace alkaloids, often in only one or two 
species or even only in one or two populations of the same species. For 
instance the pyrrolidine alkaloid 2391 [82] was only found in a single specimen 
of D. trivittatus as was 241D [83], recently isolated from D. specious.
OH
A further reason for their 'minor alkaloid' classification is that these 
compounds may not be secondary metabolites of the frogs, but assimilated 
(perhaps with some subsequent metabolism ) from food sources.28 Possible 
precursors to alkaloids found in dendrobatid frogs are found both in insect 
and plant species. Both 2,6-cis and 2,6-trans- [83] have been found in South 
African fire ants of the genus Solenopsis,29 and fr«ns-[84] has been identified 
from S. punctaticeps and the Pharaoh ant M onomarium pharaonis . 3 0  
Noranabasamine [85] (pyridyl-piperidine class) corresponds to a N-desmethyl 
analogue of anabasamine, a plant alkaloid, and the two isomeric alkaloids 
calycanthine [8 6 ] and chimonanthine [87] (though opposite enantiomers) are 
known from the North American plant genus Calycanthus (Calycanthacaeae). 
Another alkaloid which may be assimilated and perhaps metabolised from 
dietary sources is the azatricyclododecene 205B [8 8 ], reminiscent of alkaloids 
from the ladybird beetles of the family Collienllidae. For further discussion of 
the biogenesis of the dendrobatid alkaloids see 2 .2 .1 .
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2.2 Biology.
2.2.1 Biological origins.
The amphibia (frogs, toads and salamanders) produce a wide variety of 
secondary metabolites including peptides, biogenic amines, bufodienolides 
and over a dozen classes of alkaloids. The wide structural variety of the 
dendrobatid alkaloids leads to two conclusions: a) the amphibia have evolved 
complex biosynthetic pathways to produce these alkaloids, or b) precursors or 
even the alkaloids themselves have a dietary origin. Biosynthetic studies to 
date have not shed much light on the subject. In vivo studies found no 
detectable incorporation of radioactive acetate, mevalonate or cholesterol into 
the alkaloid fractions of D. pumilio or P. aurotino. Similarly, no radioactive 
serine was incorporated into the batrachotoxin alkaloids of P. aurotaenia. The
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radioactive acetate and mevalonate were incorporated, instead, into skin 
ch o lestero l . 31 Similar results were obtained in the investigation of 
tetrodotoxin (TTX) [14] biosynthesis. Radioactive acetate, arginine and 
citronelline were incorporated into cholesterol, amines and amino acids but 
not TTX in the californian newts of the genus Taricha.32 A cautionary note 
should be added here that this evidence could point to very slow alkaloid 
synthesis, with no incorporation on the time scale of these experiments.31 
Since there is the suggestion that acetate, mevalonate and cholesterol are not 
involved, an equally valid suggestion may be put forward that the 
biosynthetic pathway is similar to that of the related pyrrolizidines and 
quinolizidines. These alkaloids are derived from ornithine and lysine. There 
are in both these cases two possible starting materials. Pyrrolizidines e.g. 
retonicine [94], may be formed from ornithine [56] or putrescine [89] (Scheme 
2) and quinolizidines e.g. cytisine [97], from lysine [60] or cadaverine [95] 
(Scheme 3) .1
Biosynthesis takes place by the coupling of two putrescine or two 
cadaverine units to yield, respectively, a 5,5 or a 6,6  bicyclic alkaloid. If one 
putrescine and one cadaverine unit were to be joined a 5,6-bicyclic alkaloid 
might result (Scheme 4). This could be determined by feeding experiments 
with labeled [89] and [95]. The predicted labeling pattern is shown in [98].
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The other option, that either the alkaloids themselves or precursors to 
them are accumulated from dietary sources, is supported by the fact that toxic 
alkaloids are all but absent in the eggs and larvae of the dendrobatid frogs and 
the related TTX is absent in hatchery-raised puffer fish.33 Indeed, second 
generation laboratory reared P. terribilis have no detectable levels of 
batrachotoxin, though the alkaloid profiles of wild-caught adult frogs in 
captivity remains relatively constant fed on Drosophila for up to six years. 
The absence from the eggs and larvae could be attributable to the non­
development of the 'poison glands' at this stage or to the slow turn-over of 
alkaloid production. The lack of alkaloid production in lab reared specimens 
suggests a dietary origin of the alkaloids in their wild cousins, but this is put 
into doubt by the consistent alkaloid profiles of wild-caught adults.
The dietary origins of these alkaloids is further put in question when the 
apparently random phylogenic occurrence of TTXs is considered. TTXs are 
found in species as diverse as marine snails,34 flatworms,35 starfish,36 the 
blue-ringed octopus37 and puffer fish33 as well as in salamanders38 and 
frogs.39-40 This occurrence in marine, freshwater aquatic and terrestrial species 
suggests that a dietary origin is unlikely, though bacterial production may be 
involved.41 Further support for the dietary origins of some of the alkaloids 
comes from the isolation of morphine, a well known plant alkaloid from the 
skin extracts of the toad B. marinus .42
2,6-Disubstituted piperidines have been suggested as possible precursors to 
histrionicotoxins, gephyrotoxins, indolizidines and decahydroquinolines.43 
The recently discovered 2,5-disubstituted pyrrolidines have been suggested as 
precursors to dendrobatid alkaloids containing the indolizidine moiety, e.g. 
the pumiliotoxin A class.16 However, the existence of, for example, 5,8-
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disubstituted indolizidines cannot be rationalised using either 2 ,6 - 
disubstituted piperidines or 2,5-disubstituted pyrrolidines as precursors. These 
suggestions seem unreasonable considering the limited occurrence of these 
alkaloids (section 2.1.6). If these were the precursors, significant amounts 
should have been found in the skin extracts of most of the species 
investigated, not just the three examples known to date. Further work is 
needed in this area before any conclusions can be drawn.
2.2.2 Biological roles.
Three species of South American Phyllobates are used by the Emberá and 
Noanamá Chocó indians for poisoning blowgun darts. These species were 
chosen due to their high toxicity (we now know this is due to their high 
content of batrachotoxin [13]), which caused locomotor difficulties, 
convulsions and death. Frogs of the genus D endrobates have evolved 
simpler, less toxic alkaloids. These produce, in mice, reactions as diverse as 
Straub tail, penile erection, prostation, convulsions and salivation.18 Like 
many plant alkaloids, the dendrobatid alkaloids clearly have a defensive role. 
This conclusion is supported by the following observations: (1) the alkaloids 
are released as a milky (and sometimes odoriferous) secretion by the frogs 
upon being attacked and following any damage to the skin; (2 ) snakes, birds 
and mammals usually release the grabbed frog immediately with evident 
distaste. Humans also find frog secretions distasteful. Indeed, this is one of the 
less elegant bioassays used to determine the presence of alkaloids in skin 
secretions; (3 ) most of the toxic dendrobates are brightly coloured as a warning 
to predators, non-alkaloid-producing dendrobates of the genus Colostethus 
are inconspicuously coloured (usually brown) to avoid detection. The skin 
secretions have also been suggested to have anti-bacterial and anti-fungal
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properties these being useful functions in the dampness of a tropical rain 
forest.
Scheme 5. Biosynthetic relationships 
of dendrobatid alkaloids and precursors
36
2.2.3 Biological activity.
2.2.3.1 Cholinergic receptors.
Acetylcholine (Ach) [107] is one of the major neurotransmitters both in 
the central (CNS) and peripheral nervous systems. Ach is involved as a 
neurotransmitter in many tissues such as motor nerves, skeletal muscle and 
certain synapses in the CNS. When an action potential arrives at the 
cholinergic nerve terminal, Ach is released, crosses the synapse, binds with 
specialised cell surface receptors known as cholinergic receptors and triggers a 
response.
2.23.2 Subclassification; Nicotinic and Muscarinic receptors.
The terms 'nicotinic' and 'muscarinic' were introduced in 1914 by Sir 
Henry Dale44 to describe the effects of Ach that were mimicked by either 
nicotine [59] (from tobacco, Nicotiana tabacum) or muscarine (from the 
toadstool, Amanita muscaria). Some of the better known agonists
(stimulators) and antagonists (blockers) are shown in (Figure 4). The two 
quaternary salts DMPP [108] and PTMA [109] are nicotinic agonists, an 
antagonist being (+)-tubocurine [110]. Muscarine [111] and arecoline [112] are 
agonists of the muscarinic receptors, two antagonists being atropine [52] and 3- 
quinuclidinyl-benzilate [113].
[107]
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[109]
Figure 4. Nicotinic and Muscarinic agonists and antagonists.
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2.2.3.3 Clinical use.
The indolizidines and perhydrobenzoindolizidines (gephyrotoxins) are 
competitive muscarinic antagonists, that is they block the action of Ach at 
muscarinic sites.45 There are two types of muscarinic receptor sub-types 
denoted Mi and M2 . Mi receptors are primarily involved in higher brain 
functions, viz. learning and memory, as well as in locomotor and behavioral 
effects. Indeed, impaired central neurotransmission of cholinergic type is 
often found in Alzheimer's disease. M2 type receptors are thought to be 
primarily involved in the regulation of vegetative, sensory and motor 
functions. There is little or no published data on whether the indolizidines 
are Mi or M2 preferential. Figure 5 shows some clinically useful muscarinic 
antagonists. In clinically used doses, atropine [52] and scopolamine [114] 
induce drowsiness and mild sedation, in larger doses, hallucination and 
delirium, and in still larger doses death due to paralysis.
These are broad range effects. It is hoped that with the increasing number 
of synthetic and semi-synthetic antimuscarinic drugs available, soon organ 
and tissue selective drugs will be developed. The quaternary ammonium 
compounds methantheline [115] and glucophyrrolate [116], due to their 
charge, cross the blood-brain barrier to such a small extent that virtually no 
CNS effects are seen. Homoatropine [117], cyclopentolate [118] and 
tropicamide [119] are used in ophthalmology to cause dilation of the pupil. 
Atropine [52] and scopolamine [114] were used in the form of belladonna 
extract for the same purpose in Victorian times, to dilate the pupils and give 
the desired and desirable (in those times) wide eyed innocent look to young 
ladies. Iratropium [120] and oxitropium [121] are administered in aerosol form 
to cause bronchial dilation. Trihexylphenidyl [122], procyclidine [123] and 
biperiden [124] cross the blood-brain barrier with ease, acting centrally to
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reduce Parkinson-like symptoms by restoring the balance of cholinergic and 
dopaminergic neurotransmission though undesirable side effects such as 
hallucinations may limit the usage.
[122] 1123] [124]
Figure 5. Clinically used Muscarinic antagonists
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2.2.3A Structural requirements of muscarinic antagonists.
Several structural elements seem to be common to all these agents:44
• a 'cationic head' group;
• some sterically 'blocking' moieties (e.g. an alicyclic/aroma tic system);
• some structural element (e.g. ester group) linking the above two;
• anchoring groups (e.g. OH) that contribute to the total binding.
As might be expected, agonists and antagonists are often structurally similar. 
Both need to bind to the receptor in question, one eliciting a response, the 
other no response. The requirements for an agonist seem to be:
• a 'cationic head' group;
• either lipophilic (alkyl groups) or electron-rich (e.g. ester group, triple bond) 
moieties.
As a rule of thumb, Ing's five atom rule46 holds true for many muscarinic 
agonists. This states that there should be a five-atom chain attached at one 
end to a quaternary nitrogen, the other terminating in a methyl group [1 1 1 ],
[125] . Studies on the muscarinic agonist arecaidine proparagyl ester analogues
[126] showed that unsaturation in the side chain increased the potency with 
respect to fully saturated esters.44
R  R -  M e. E l  "Pr
[ 111] [125] [126]
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Dendrobatid indolizidines fulfil many of the criteria for both agonists and 
antagonists. For example, the 3,5-disubstituted 223AB [70] and 239AB [71], 
along with all the known 5,8-disubstituted indolizidines, e.g. 203A [73] and 
235B [127] fulfil Ing's five atom rule. They have the required charged head 
group (at physiological pH), contain alicyclic 'blocking groups' and have 
'anchoring groups' such as hydroxyl groups and unsaturation in the side 
chains. So, some agonist/antagonist behaviour could be predicted from the 
above. Experiments on mixtures of the indolizidines would seem to agree 
with this, but clearly tests would have to be carried out on pure compounds to 
gather more detail on the agonist/antagonist structural requirements. The 
indolizidines would seem ideal, in the range produced by dendrobatid frogs 
and structural analogues, to probe the muscarinic receptors, gather structural 
information about the receptors and perhaps be of clinical use.
[70] [71]
[73] [127]
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2.3 Chemical syntheses.
2.3.1 Racemic syntheses.
The syntheses of racemic (±)-indolizidines 167B [67] (Scheme 6 ), 205A [74] 
and 207A [75] were first reported by Holmes et al. 47,48 intramolecular 
cycloaddition of the (Z)-N-alkenyl nitrone [131] prepared in seven steps from 
2-pentanone [128], gave the isoxazolidine [132]. Alkaline hydrolysis of the 
acetate group, mesylation, accompanied by spontaneous cyclization and 
reductive N-O bond cleavage with Zn/AcOH furnished the 5,8-disubstituted 
indolizidine [133]. Removal of the C -8  hydroxy-methylene substituent was 
achieved by oxidation to the carboxylic acid, then decarboxylation via the 
seleno-ester yielding (±)167B [67]. The three new steroegenic centres in [133], 
the 5, 8  and 9 positions were controlled by the single stereogenic centre a  to 
the nitrogen in nitrone [131]. This method has been extended to (±)-235B [127] 
and to the asymmetric synthesis of (-)-209AB [76], discussed in section 2.3.4.
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Scheme 6
Commins et al,*9 through investigations in the chemistry of N - 
acyldihydropyridones, prepared (±)-209B [76] in seven steps from 4- 
methoxypyridine [134] (Scheme 7). Dihydropyridone [137] was prepared from 
4-methoxypyridine [134] and Grignard reagent (i), after protection of the 
amine with benzylchloroformate.  Chlorination  with N -  
chlorosuccinimide/triphenyl phosphine, followed by stereoselective 
méthylation and cuprate addition gave [138]. Hydrogenation with palladium 
to remove the Cbz group, platinum catalyzed hydrogenation to reduce the 
carbonyl and Barton deoxygenation yielded (±) 209B [76].
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2.3.2 Asymmetric syntheses
A symmetric synthesis would, by definition, produce a statistical mixture 
of enantiomers and diastereomers i.e. a racemate. An asymmetric synthesis, 
to be anything other than a mechanistic curiosity, needs to produce one of the 
possible enantiomers in greater than 90% e.e. The new chiral centres need to 
be supplied by the substrate, the reagent or a catalyst present. Aitken and 
Kilenyi 50 propose the following classification of asymmetric syntheses.
2.3.3. First generation or substrate controlled methods.
The ultimate source of chirality is nature. Amino acids (with few 
exceptions) are of the L variety whilst natural carbohydrates are of the D 
variety. This provides a vast 'chiral pool' of readily available starting 
materials. Several syntheses of indolizidines have made use of chiral natural 
products to introduce stereochemistry.
(-)-Indolizidine 167B [67] has been prepared using D-norvaline [141] as the 
chiral building block (Scheme 8 ).51 The pyrrole [142] formed from the 
condensation of 2,5-dimethoxytetrahydrofuran and D-norvaline [141] was 
converted to the a-diazo ketone [143]. Arndt-Eistert homologation (to 
introduce the extra methylene group) gave the second a-diazoketone [145] 
which, upon rhodium acetate-mediated cyclization, gave the (J-keto pyrrole 
[146]. Hydrogenation with Adams catalyst under acidic conditions yielded the 
desired (-)-167B [67].
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Using the rigid amino acid equivalent (S)-pyroglutamic acid [147] Fleurant 
et al 52 also synthesised (-)-167B [67] (Scheme 9). (S)-pyroglutamic acid [147] 
was converted to the methyl ester [148] in five steps by one-carbon 
homologation using nitrile chemistry. Reduction and N-protection yielded 
the alcohol [150] which was subjected to Swern oxidation and subsequent 
Wittig elongation to give the a,P-unsaturated ketone [152]. Hydrogenation 
over platinum oxide gave the ketone [153] which was further hydrogenated 
over palladium. This accomplished the reduction of the amide to an amine 
functionality and N-deprotection, with subsequent cyclization and reduction 
of the iminium [154] thus produced to the indolizidine (-)-167B [67].
47
[154] (->[67]
Scheme 9
Amino acids are not the only natural products that have been used for the 
synthesis of 5-mono- and 5,8-di-substituted indolizidines. Aub6 et al began 
their synthesis of (-)-209B [76] with pulegone [155] (Scheme 10).53 Pulegone 
[155] contains the 8-methyl group required for (-)-indolizidine 209B [76]. Ring 
contraction of pulegone [155] via Favorskii rearrangement, and conversion to 
the (}-keto ester [156] was first reported by Marx and Norman.54 Here the trans 
isomer is produced predominantly (cis:trans, ca 1:13); the c is  isomer 
ultimately removed by fractional crytallisation. Protection of the keto-group 
of [156] yielded the acetal [157] which was reduced to the primary alcohol [158]. 
The alcohol [158] was then oxidised to the aldehyde and submitted to Homer-
48
Emmons extension resulting in the a,p-unsaturated ester [159]. Dissolving 
metal conditions reduced the ester and the alkene functionalities and 
Mitsunobu conditions were used to produce the azide [160]. Ketal removal 
and an intramolecular Schmidt reaction yielded, after recrystallisation, 
enantiomerically pure [162]. Attack by n-pentyl magnesium bromide and 
stereospecific reduction of the iminium ion intermediate [163] yielded (-)- 
209B [76].
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As mentioned before, Holmes et al have used the nitrone methodology 
shown in Scheme 6  to synthesise the indolizidines (±)167B[67], (±)205A[74], 
(±)207A[75], (±)235B[127] and (±)235B[164]. This methodology has also been 
used to produce enantiomerically pure indolizidines.
In the Holmes synthesis of (-)-indolizidine (-)-209B [76],48 Holmes and co­
workers used the nitrone [131] as the reagent. The synthesis of (-)-209B (->[76]
4 .
started with the preparation of the enantiom erically pure N- 
alkenylhydroxylamine [166] (derived from the chiral amino alcohol [165]) 
(Scheme 11). This was achieved in 12 steps, using a chain extension sequence. 
The nitrone [167] was produced and converted into (-)-209B [76] using a 
previously reported sequence.47
[1641
[165] [166]
[167]
Scheme 11
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Polaniaszek and Belmont55 undertook a synthesis of indolizidines (-)-167B 
[67], and (-)-209D [183] and their diastereomers from (SM-)-a-phenethylamine 
[169] (Scheme 12). The aldehydes, [175] produced in five steps from succinic 
anhydride [168] and (S)-(-)-a-phenethylamine [169] were converted to the 
corresponding dimethyl acetals [176] and [177] which were separable by MPLC. 
The major isomer [176] was hydrogenated using Pd/C to deprotect the amine, 
then hydrolysed in the presence of hydrogen cyanide to remove the acetal 
with concomitant cyclization and trapping of the iminium ion with cyanide. 
This produced the amino nitrile [179] as a single isomer. This amino nitrile 
thus served as a late-stage common intermediate which upon treatment with 
an appropriate Grignard reagent, furnished [180] and [181]. Treatment of [179] 
with base and an alkyl bromide gave [182] followed by sodium borohydride 
reduction produced the epimers (-)-167B [67] and (-)-209D [183].
S-(-)-cx
phenethylamine
I1 6 9 ] i J  \ LiEtBH,
° ^ (
(i) SnCI«.
o S 5 % ^ ° 3 H  (ii) allyl trimethyl
Ph Ph
silane
[168[ [170| [171]
^
UAIH4
H ^ T 'M e H ^ i ' M e
Ph
( 18% )
Ph
( 8 2 % )
Ph
[172] [173| [174]
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[182]
(-)(B7] R -n-Pr 
(-)[183) R-n-Hex
Scheme 12
2.3.4 Second-generation or auxiliary-controlled methods
In the auxiliary-controlled approach, control is again achieved 
intramolecularly by a chiral group in the substrate. The difference is that the 
'chiral auxiliary' directing the control is now deliberately attached to an 
achiral substrate and removed later in the synthesis once the stereocontrol 
has been achieved. Examples of this are the Meyers oxazolidine [184] and 
Oppolzer's camphor sultarns [185].50
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The asymmetric synthesis of (+)-209B [76] was approached by Gnecco 
et al56 by utilising the innate chirality of (RM-)-phenyl glycinol [187] in the 
pyridinium salt [188], (Scheme 13) gained from the Zinck's salt [186]. 
Reduction with sodium thiosulphate yielded the 1,4-dihydropyridine [189] 
which cyclised to the two oxazolidines [190a] and [190b] when filtered through 
alumina. These, being masked iminium ions, upon treatment with «-pentyl 
magnesium bromide cleaved the heterocycle replacing oxygen with a pentyl 
group. Spontaneous cyclization again occurred on filtering through alumina 
to yield the two new oxazolidines [191a] and [191b]. These were again 
selectively cleaved with a Grignard reagent producing a mixture of the 
piperidines [192], [193] and [194] only, in the ratio, 5:3:1. Separation on silica gel 
and subsequent hydrogenation yielded (+)-209B [76], (-)-209B [76] and the 
diastereomer [195].
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2.3.5 Third-generation or reagent controlled methods.
In the third-generation methods, in contrast to first and second, the 
stereocontrol is intermolecular, the reagent, not the starting material, being 
homochiral. In the area of the 5-mono or 5,8-disubstituted indolizidine 
synthesis there is no clear example to illustrate this method of asymmetric 
induction.
2.3.6 Fourth-generation or catalyst-controlled methods.
A chiral catalyst removes the need for a stoichiometric amount of an 
enantiomerically pure compound. This is an attractive refinement to the 
methods detailed above. At the moment there are limited numbers of 
synthetic chiral catalysts, though there are a number of synthetically useful 
enzymes.
An example of the use of chiral catalysis is the exploitation of the 
Sharpless epoxidation by Satake et a l 57 in the synthesis of (-)-209B [76], (-)- 
235B [127] and (-)-205A [74] (Scheme 14). The alkenyloxirane [198] was prepared 
from the allylic alcohol [196] by sequential Sharpless epoxidation, Swern 
oxidation and Emmons-Horner chain elongation, the Sharpless epoxidation 
introducing the two new chiral centres in the form of the epoxide [197]. 
Hydrogenolysis of [198] with a palladium catalyst in formic acid gave the 
homochiral alcohol [199]. This was converted to the iodide [201] in seven steps 
via the azide [200]. Cyclization gave the bicyclic ketone [202] as a late stage 
common intermediate for the synthesis of the indolizidines. Treatment with 
the appropriate Grignard reagent and sodium cyanoborohydride reduction 
yielded (-)-209B [76], (-)-235B [127] and (-)-205A [74].
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Momose used a lipase to prepare the homochiral piperidine [204] from the 
diacetate [203].58 Protection and reduction of [204] gave the a,|i-unsaturated 
ester [205] which underwent stereospecific methyl addition to produce what 
would become the 8 -methyl group of the indolizidines (-J-207A [75], (-)-209B 
[76] and (-)-235B' [164]. Reduction gave the alcohol [207] which, under Swem 
oxidation conditions, followed by Wittig-Horner chain elongation of the 
resulting aldehyde, gave a 4:1 mixture (E:Z) of the a,p-unsaturated ester [208]. 
Catalytic hydrogenation followed by Super-hydride reduction of the 
intermediate aldehyde and protection of the resultant alcohol furnished [209], 
which was then converted to the iodide [210]. Copper iodide mediated
57
Grignard cross-coupling followed by deprotection of both the alcohol and the 
amine led to intra-molecular cyclodehydration via the alkoxy phosphonium 
salt when exposed to PPh3 /C Br4 and triethylamine (first reported by 
Machinaga59). This forms (-)-235B'[164] (Scheme 15). The syntheses of (-)-207A 
[75] and (-)-209B [76] were also reported by Momose.58
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2.4 Summary of New Methodology
(L)-Glutamic acid [211] and the 5-mono and 5,8-disubstituted indolizidines 
[212] and [213] have several structural similarities.
(L)-Glutamic acid [211] has an amine which is a  to the chiral centre (*) of the 
same absolute configuration as the parent indolizidines [212], [213]. The 8-acid 
function is suitably positioned to facilitate formation of C(8)-C(9) bond of the 
indolizidines and allow installation of the 8 -substituent. In view of this, L- 
glutamic acid was used as a starting point for the construction of the 
indolizidine skeleton.
The missing 4-carbon fragment could be supplied by pyrrole formation 
which would permit intramolecular Friedel-Crafts acylation to form the 
important C(8)-C(9) bond. Reduction of the a-ketopyrrole [214] so produced 
should furnish the indolizidine alcohol ester [215]. The C(5) ester group was 
expected to direct the hydrogenation to the endo face of the molecule thus 
giving cis addition of H2 and setting up the correct relative stereochemistry as 
in [215].
[211] [212] R = H,
R' = alkyl, alkenyl
[213] R » Me
R' = alkyl, alkenyl
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[214] [215]
Conversion of the 8 (S)-hydroxyl group to an appropriate leaving group 
and an Sn 2 methylation would provide the 8 (R)-methyl group of the 5,8- 
disubstituted indolizidines. Homologation of the 5-ester group should lead to 
the desired indolizidine side-chains.
2.5 Pyrrole formation
There are several methods by which pyrroles may be produced,
2.5.1 Reaction with conjugated diynes.
Ammonia and primary amines [216] (both aliphatic and aromatic) add to 
conjugated diynes [217] to produce pyrroles [218] (Scheme 16).60
[216] [217]
R
[218]
Scheme 16
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2.5.2 Reaction with y-dicarbonyls.
Pyrroles are readily synthesised from primary amines and y-dicarbonyl 
compounds. Paal and Knorr reported that N-substituted 2,5-dimethyl pyrroles 
[221] were prepared from the corresponding amine [219] and acetonylacetone 
[220].61'62 This is now known as the Paal-Knorr pyrrole synthesis (Scheme 17).
2.5.3 Reaction with 2,5 disubstituted tetrahydrofurans.
Simple N-substituted pyrroles [224] can be derived from primary amines 
e.g. [2 2 2 ] and 2 ,5 -d im eth oxy tetrah y d rofu ran  [2 2 3 ]63 or 2,5-
dichlorotetrahydrofuran. The use of 2,5-dimethoxytetrahydrofuran [223] is 
preferable (Scheme 18), as it is more stable.
[222] [223] [224]
Scheme 18
The last of these three routes was considered preferable, since Kashima 
and co-workers64 had already synthesised the pyrrole dimethyl ester [224] and
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reported that the N-pyrrole formation proceeded with no significant 
racemization. Indeed, they found that when phenylalanine was the starting 
material, retention of the optical activity of the amino acid from pyrrole 
formation and cleavage was in excess of 99%. So, we were confident in the 
configurational integrity installed by the choice of L-glutamic acid as the 
chiral starting material.
2.5.4 Results and Discussion.
The synthesis of [224] was first attempted using the conditions described by 
Kashima. However, the modified Clauson-Kaas procedure described by 
Jefford65 proved more successful. Hence 2,5-dimethoxy tetrahydrofuran [223] 
was added to the hydrochloride of L-glutamic acid dimethyl ester [224] in 
acetic acid with an excess of sodium acetate (Scheme 19).
[222]
Scheme 19
[224]
The previously unreported N-pyrrole diacid [225] was also prepared from 
L-glutamic acid [211] using the conditions described above, as racemization in 
the form of the diacid would be less likely. Characterisation of this was
undertaken using 1H and 13C NMR as CHN and accurate mass measurements 
were problematic, possibly due to decomposition. Problems were also 
encountered with the CHN analysis of other samples that were liquids due to 
calibration and general difficulties of handling oils. Diacid [225] was converted 
to either the dimethyl or diethyl ester by refluxing in the appropriate alcohol 
in the presence of the acidic ion-exchange resin Amberlyst 15.
The diethyl ester [227] was recently reported by Jefford65 to be prepared in 
good yield by the alternative conditions of water at 80°C for 30 minutes. 
Investigations were undertaken on the preparation of the diester analogues 
under both the modified Clauson-Kass and Jefford's procedures. This showed 
that some epimerization had occurred during the reaction in glacial acetic 
acid (Scheme 20), Table 1. This was confirmed by a later paper66 by Jefford who 
investigated the preparation of both the diester analogues and found their 
method to be superior in avoiding racemization.
HCI.H2N CO2R
[222] R -  Me 
[220] R -  Et
[224] R -  Me 
[227] R -  Et
[225]
Scheme 20
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Entry Educt Procedure® Product Yield, % [a]D*
1 222 A 224 70 -2 8 .6
2 222 B 224 23 -33 .5
3 226 A 227 83 -1 6 .6
4 226 B 227 70 -22 .1
5 225 C 224 4 4 -29 .9
6 225 C 22 7 52 -1 7 .0
@ Procedures; A - Acetic acid, reflux, 30 mins; B - Water, 80 deg, 30 mins; C - Amberlyst 15, 
ROH, reflux 2 days.
’ At this time it should be mentioned that [a ]o  values can only be strictly compared if the 
concentration of the sample and the other variables are in accordance.
Table 1
This data shows that epimerization is indeed a problem even in the 
preparation of the diacid [225], despite the literature precedent. So, preparation 
of the pyrrole diethyl ester under Jefford's non-epimerizing conditions was 
undertaken a) to avoid epimerization, b) as the yields for the ethyl ester are 
higher than those of the dimethyl ester under these conditions and c) L- 
glutamic acid diethyl ester hydrochloride is cheaper than its dimethyl ester 
hydrochloride and purification by distillation of the ethyl ester pyrrole [227] 
gave better yields than the methyl ester [224].
2.6 Cydization.
2.6.1 Introduction.
There are two possible entries into the bicyclic pyrrole system, the first 
being the formation of the N-substituted pyrrole [228] with the subsequent 
cyclization at the pyrrole a-position yielding [229] (Scheme 21). The second
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was the formation of an a-substituted pyrrole [230] followed by subsequent N- 
acylation to yield [231] (Scheme 22).
[230] [231]
Scheme 22
The first of the two possibilities allowed a first-generation method of 
attaining the C(5) chiral centre of the parent indolizidines. The second route 
did not lend itself to installation of chirality in this way. Also, the second of 
the two methods requires selective prior a-acylation of pyrrole, which can be 
problematic and is often accompanied by intermolecular acylation.
2.6.2 Methods of C-acylation of pyrroles.
Most of the literature precedents for C-acylation of pyrroles at the ex­
position have been carried out on pyrrole itself or simple alkyl or aryl 
derivatives e.g. 1-methyl, 2,4-dimethyl, 2,3,5-trimethyl and 2,3,5-triphenyl 
pyrrole.67 Formylation, either at the a- or the P-position has been extensively
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carried out on simple pyrroles using the Gatterman reaction. This involves 
the addition of anhydrous hydrogen chloride to a solution of the pyrrole [233] 
and hydrogen cyanide (or zinc cyanide in ether or chloroform.)68-69'70 The 
intermediate iminium salt [234] is hydrolysed during the work-up. Meinwald 
and Meinwald71 used this method to synthesise [235], the major component 
of the hairpencil secretion of the butterfly Lycorea ceres ceres (Scheme 23).
[236]
Scheme 23
They found that only one of the possible cyclization products [235] was 
formed. They put forward the explanation that selective activation of C-2 by 
the 3-methyl group to the intramolecular electrophilic substitution produced 
[235] rather than [236].
The Vilsmeier-Haack synthesis, the use of benzoyl chloride in conjunction 
with DMF,72 fails to produce a-formylated pyrroles73 if the molecule contains 
electron-withdrawing groups. Ethyl orthoformate in the presence of a Lewis 
acid catalyst has been used to formylate phenol and azulene.74-75 Clezy et al 76 
found formylation was easily effected by reaction of ethyl orthoformate in the 
presence of trifluoroacetic acid. They used this method to produce a wide
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variety of a- and p-formyl pyrroles, though they found that this was most 
effective when the desired product contained the P-formyl group.
It can be concluded from this that the most promising method of a-C - 
acylation would be the intramolecular reaction of either the diacid [225] or the 
diesters [224] and [227]. This would avoid the problems of (i) C- vs N-acylation 
(selection between the N-acyl and C-acyl products can be achieved by either 
addition of a base (e.g. triethylamine) to favour the former or the addition of a 
Lewis acid or a trace of sulfuric acid to ensure C-acylation of the pyrrole77) and 
(ii) a- vs p-acylation. The length of the methylene tether would favour, both 
kinetically and thermodynamically, the formation of a 6  us 7 membered ring.
In summary, the electron-rich pyrrole system coupled with the 
conformational restraints of an intramolecular reaction was expected to effect 
facile C-acylation at the a-position of the pyrrole ring to produce the a-keto 
pyrroles [237], [214] and [238] (Scheme 24).
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Scheme 24
Friedel-Crafts acylation is effective using acyl halides, carboxylic acids, 
anhydrides, ketones78 and esters (though alkylation products are often a 
problem). Reactive pyrroles may be formylated under mild conditions by 
reaction in the presence of a Lewis acid such as stannous chloride or 
aluminium chloride,79 though a loss of selectivity is seen and, due to the
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heterogeneous nature of the pyrrole/acid catalyst complex, polymer 
formation is often a problem. Other Friedel-Crafts catalysts that have been 
used include magnesium perchlorate,80'81 stannic chloride,82 FeCl3, 12, ZnCl2 , 
Fe as well as proton acids such as polyphosphoric acid (due to its high 
potency) and sulfuric acid, though the use of these is usually restricted to 
where the substrate itself is an acid.
Cyclization of a 3-substituted pyrrole acid [239] was achieved by refluxing 
with polyphosphoric acid yielding the bicyclic pyrrole [240]. (Scheme 25).83 
Volz and Draese84 undertook a similar cyclization of the pyrrole [241], 
yielding a mixture of products [242], [243]. (Scheme 26).
[239] , [240]
Scheme 25
The fact that pyrrole can be acetylated with acetyl trifluoroacetate85  and 
that pyrrole acetylation is catalysed by boron trifluoride,86 as well as the 
examples above, encouraged us to look at other, newer Friedel-Crafts catalysts 
to effect the cyclization. Trifluoromethanesulfonic acid [244] (triflic acid) and
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derivatives, e.g. trimethylsilyltrifluoromethane sulfonate [245] first reported 
by Haszeldine and Kidd,87'88 has many advantages over other add systems:89
• It is one of the strongest adds known;
• It is non-oxidizing;
• It doesn't provide fluoride ions;
• It possesses superior thermal stability and resistance to both 
oxidation and reduction;
• The reaction is homogeneous thus reducing possible polymer 
formation.
Me fl
i r CF3
M e-S i—0 - | i —CF3
0 Me O
[244] [245]
Butler and Kray have shown that triflic acid is superior to aluminium 
chloride in the acylation of p-xylene90 and in alkylation.91
Marsman92  measured the 29Si-NMR shifts of a series of trimethylsilyl 
derivatives (CH3 )3SiX where X ranges from CN, Br, F, Cl to SO4 , CIO4 , 
OSO2CF3 . They estimated pKa values of these Lewis acids and showed 
perchlorate and triflate were stronger acids than the others in the series. A 
major advantage of the triflate and others of these novel catalysts over SnCU 
is their lowered Lewis acidity. This dramatically reduces the a-com plex 
formation with silylated bases, a natural consequence being the higher yields 
and increased catalytic activity. This is especially well illustrated in nucleoside 
chem istry .93  Other advantages over the more "classical" Friedel-Crafts 
catalysts are mild reaction conditions, easy work-up and, in many cases, 
improved stereoselectivity.
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Initial attempts at Friedel-Crafts acylation were undertaken on the pyrrole 
dimethyl ester [224] with trimethylsilytrifluoromethane sulfonate (TMSOTf) 
as the catalyst. Though no literature precedents could be found for the use of 
TMSOTf in Friedel-Crafts cyclization of pyrrole systems, this catalyst was 
investigated with some confidence due to general synthetic utility as a Lewis 
acid.
2.6.3 Results and discussion.
The cyclization was first attempted on the dimethyl derivative as this was 
the first produced and on the diester rather than the diacid due to the relative 
ease of purification and general working with the diester. TMSOTf, in theory, 
could be used in catalytic amounts. In normal Friedel-Crafts acylation (e.g. 
AICI3) more than one equivalent is needed as the first equivalent co­
ordinates to the carbonyl functionality and remains co-ordinated until work­
up destroys this complex [248] (Scheme 27).
0
u +
r x i
A103 ------► Y A,cl3
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Scheme 27
Therefore, the use of 1.1-1.3 equivalents may be required. Vorbrüggen et 
al93 has noted the possible catalytic use of TMSOTf and the practical use of 
more than stoichiometric amounts. They put this down to o-com p lex  
formation between TMSOTf and the silylated base [249] (Scheme 28). This 
inactivates one equivalent of the TMSOTf, using 1.1-1.3 equivalents 
dramatically speeds up the reaction and makes the conditions easier to work
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with. Alternatively the catalyst was not strong enough to convert the 1 -0
We also found that the use of TMSOTf did not give practical yields with 
less than six equivalents of TMSOTf. TMSOTf,-being a strong' Lewis acid, can 
accept electron density from the many electron-rich moieties, e.g. double 
bonds, esters and the tertiary amine. So, the pyrrole dimethylester [224] can co­
ordinate five equivalents of TMSOTf and the sixth and further equivalents 
undertake the reaction. As TMSOTf is relatively expensive, the need for six 
equivalents (as well as the 72 hour reaction time) was not ideal.
acetyl-2,3,5-tri-O-benzoyl-p-D-ribofuranose [250] to the reactive electrophilic 
sugar cation [253].
OSi(CH3)3
OBzOBz [251] [252]
[250]
Scheme 28
[253]
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Previous work,64 indicated that polyphosphoric add (PPA) had been used 
to cause the intramolecular acetylation of pyrroles where the carbonyl 
functionality is an acid. The diadd [225] was refluxed with PPA but produced 
only baseline material. This was attributed to possible polymer formation due 
to the second acid group undergoing intermolecular acylation forming 
polymeric species or intramolecularanhydride formation. This being 
plausible, the mono add [254] was investigated as a model system. Add [254] 
was prepared from glycine and 2,5-dimethoxy tetrahydrofuran. This 
underwent efficient cyclization under conditions which failed for the diacid 
(Scheme 29).
[254] [255]
Scheme 29
Having discovered that the a-carboxyl function appeared to be interfering 
with the TMSOTf reaction it was reinvestigated on the monoester [256], the 
synthesis of which was attempted from the mono acid [254] and anhydrous 
HCl/MeOH. The expectation was to observe a small amount of the Friedel- 
Crafts acylation product as a by product in this reaction but in fact the 
acylation product [255] was the major one, in preference to [256] (Scheme 30).
72
Scheme 30
Having discovered that the cyclization can be affected with HCl/MeOH, 
the cyclization of the diacid [225] was investigated under these conditions. It 
was found that similarly, intramolecular acylation with concomitant 
esterification of the a-acid gave The a-keto pyrrole [214] as the major product 
(Scheme 31).
[225]
5-10% 50-60%
Scheme 31
Finding that a simple acid could be used to cyclize this system the acidic 
ion-exchange resin Amberlyst 15 was studied, as the experimental conditions 
and work-up were expected to be very straightforward. Indeed, reflux for three 
days gave good yields of the desired a-ketopyrrole ester.
In summary, methods have been developed for the cyclization of pyrrole 
diacid and diesters [225], [224] and [227] using TMSOTf, HCl/alcohol, PPA and 
Amberlyst 15 (Scheme 32). Table 2 compares these methods as well as that 
recently published by Jefford et a/,65 where cyclization is undertaken by BBr3-
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[225] R = H 
[224] Me
[227] Et
[214] R -  Me 
[238] Et
Scheme 32
Entry Educt Catalyst Product Yield(%)
1 225 Amberly st/MeOH 214 47
2 224 HCl/MeOH 214 59
3 224 TMSOTf 214 50
4 224 PPA 214 24
5 224 Amberlyst/MeOH 214 56
6 224 BBr3 214 80
7 227 HCl/EtOH 238 24
8 227 TMSOTf 238 13
9 227 PPA 238 18
10 227 Amberlyst/ EtOH 238 54
11 227 BBr3 238 89
Table 2
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2.7 Reduction of a-Keto pyrroles.
2.7.1 Summary of new methodology
Having obtained the a-ketopyrroles [214] and [238] in two steps from from 
L-glutamic acid [211], or its commercially available alkyl ester hydrochlorides 
[2 2 2 ] or [226], reduction of the pyrrole ring and, hopefully, concomitantly the 
carbonyl functionality was necessary. The use of the 5-ester functionality to 
direct the hydrogenation towards the opposite side of the planar ring system 
was anticipated. This directing effect can only be achieved using a 
heterogeneous system, as adsorption at a surface is needed for the hydrogen to 
have a large effective steric requirement. This being so, the method of choice 
to effect this reduction was conventional catalytic hydrogenation.
2.7.2 Catalytic hydrogenation.
Pyrroles are more difficult to hydrogenate than carbocyclic aromatics and 
the reactions are usually undertaken in acidic media. This is probably because 
the acid neutralizes the inhibiting effects of the amine products. Reductions 
may proceed stepwise through intermediate pyrrolines.94
2.7.3 Catalysts.
A variety of catalysts have been used in the hydrogenation of pyrroles. 
Platinum oxide has been used often,95  though for low pressure 
hydrogenations Rh/C or Rh/Al2C>3 have been found to be better, as in the 
reduction of [257] to [258] (Scheme 33).96
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However, means of selectively reducing the keto group or the pyrrole ring 
have proved elusive. High temperatures and pressures over nickel and 
ruthenium are often required for reduction and so are of limited use. Facile 
hydrogenation of [259] occurs over 5% Rh/C to afford [260] (Scheme 34) 
originally assigned as cis 97 and then later as trans.9S
Hydrogenation over platinum in 6M HC1 reduces the a-keto pyrrole [146] to 
the indolizidine (-)[67] (Scheme 35).51
Scheme 35
Since reduction of the pyrrole system to the indolizidine and the carbonyl 
group to the alcohol was required, use would be made of rhodium on 
alumina in dry methanol in the presence of catalytic sulfuric acid.
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2.7.4 Results and discussion.
Preliminary studies were carried out on the model system [255]. 
Hydrogenation with rhodium on alumina gave a mixture of 
diastereoisomeric products (±)[261a] and (±)[261b] (which we were not able to 
separate completely) as well as the fully reduced compound (±)[262] in the 
ratio of >15 : 1. The catalyst was changed to Pd/C to see if one product would 
be favoured over the other. This also yielded a mixture of the alcohols and 
fully reduced products in the ratio 1 : >18 (Scheme 36).
(±)[261a] (±)[261b] (±)[262]
Catalyst [281] : [282]
Rh/AI203 >15 : 1
Pd/C 1 : >18
Scheme 36
As previously discussed, the facial directing effect of the ester group in 
[214] was expected to introduce stereochemical control in the hydrogenation. 
Indeed, for both [215] and [263], only one diastereomeric product was observed, 
corresponding to the expected reduction from the face away from the ester 
group (Scheme 37).
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Catalyst [215]: [263]
Rh/Al20 3 7 : 1
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Scheme 37
Further investigations showed that using the conditions of rhodium on 
alumina with no acid present gave only the alcohol [215] as the sole product 
and palladium on carbon with acid gave only the fully reduced compound 
[263] (Scheme 38).
Scheme 38
By judicious choice of catalyst and presence or absence of acid, the 
common intermediate [214] can be used to prepare either the fully reduced 
indolizidine skeleton [263] or the 8 (S)-alcohol [215] as the sole product." This 
hydrogenation process was also extended to the ethyl esters [264] and [265].
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2.8 Hydrogenation Studies.
2.8.1 Introduction.
Optically pure building blocks [215], [263], [264] and [265], for the synthesis of 
5-substituted and 5,8-disubstituted indolizidines were readily accessible in 
three steps from L-glutamic acid [211], or its commercially available 
hydrochlorides of the alkyl esters [222] and [226]. Palladium on carbon under 
acidic conditions catalyses highly diastereo- and chemo-selective 
hydrogenation of [214] and [238] to yield [263] and [265].
Furthermore, we have discovered that rhodium on alumina as catalyst, in 
the absence of acid, permits equally diastereo- and chemo-selective synthesis 
of the alternative hydrogenation products [215] and [264] (Scheme 39).
Although the high diastereoselectivity in the hydrogenation of 
compounds [214] and [238] was expected from literature precedent,51 it is 
interesting to note the high degree of chemoselection by hydrogenation could 
be controlled by changing from palladium on carbon in the presence of acid to 
rhodium-on-alumina without acid.
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[224] Me
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[238] Et
/  \
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Scheme 39
Inspection of the hydrogenation products [215] and [263] indicated that they 
might arise from totally different reaction pathways. Palladium is known to 
hydrogenolyse diaryl keto groups e.g. p,p'-dihydroxybenzophenone [266] 
(Scheme 40).100
Palladium also hydrogenolyses the keto group if it is an a,p-unsaturated 
system e.g. [268] to [269],101 whereas if the keto group is P to an aromatic 
system then the product is an a, p-unsaturated ketone [271], prepared from 
the bicyclic ketone [270] (Scheme 41).102
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[270] [271]
Scheme 41
Generally, palladium makes the most useful catalyst for hydrogenolysis of 
aromatic ketones, as it combines a good activity for hydrogenation and 
hydrogenolysis of the carbonyl with low activity for hydrogenation of the 
aromatic nucleus.100
Roy and Wheeler103 showed that in the a,p-unsaturated lactone [272], 
hydrogenation with rhodium as the catalyst yielded the dihydro derivative 
[273], showing preferential hydrogenation of the double bond with respect to 
the keto-functionality. Treatment with methanolic KOH effected 
isomerization of the double bond to give the a, P unsaturated lactone [274] 
and subsequent hydrogenation over rhodium yielded the hydroxy lactone 
[275], (Scheme 42).
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[272] [273] [274]
[275]
Scheme 42
In the field of pyrrole chemistry both rhodium on carbon and rhodium on 
alumina have been used; rhodium on carbon to catalyze the reduction of the 
bicyclic pyrrole [276] to pyrrolizidine [277]104 and rhodium on alumina to 
catalyze the reduction of the ketone [278] to the alcohol [279].105 Jefford102 used 
rhodium catalysed hydrogenation to affect the full reduction of the 5,6-bicyclic 
ketone [270] to the substituted indolizidine [280] (Scheme 43).
[278] [278]
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Rh/AljOj, H2
[270] [280]
Scheme 43
A possible explanation is that during hydrogenation of the a-keto pyrrole 
[214] with palladium, the ketone, while in conjugation with the pyrrole, was 
reduced to the methylene compound [282] with subsequent hydrogenation of 
the pyrrole yielding the indolizidine [263]. With rhodium, reduction of the 
pyrrole might occur first, the non-conjugated ketone [281] would then be 
unlikely to be hydrogenated to the indolizidine [263] but would instead 
proceed to the corresponding alcohol [215] (Scheme 44). To test this hypothesis 
the proposed intermediates were prepared ([281] and [282]) and submitted to 
hydrogenation conditions.
[281] [215]
[282] [263]
Scheme 44
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2.8.2 Results and discussion.
Swern oxidation106 of alcohol [215] proceeded smoothly to yield the ketone 
[281]. This was ascertained both by 1H and 13C NMR. Both the alcohol 
resonance and the C(8 ) H resonance at 8  = 3.78 ppm in the 1H NMR were 
absent in relation to the starting material. In the 13C NMR the appearance of a 
second resonance in the carbonyl region, along with that of the methyl ester, 
confirmed that oxidation had taken place. Due to the unstable nature of the 
product, no further analytical evidence was gathered and the crude ketone 
was used in the hydrogenation reactions with no further purification.
As alcohol [283] was also an attractive substrate for the studies, it was 
prepared from the ketone [214]. However, borane/dimethylsulfide 
reduction107 of the ketone [214] was found to proceed directly to the 
methylene analogue [282] (Scheme 45), as indicated by the absence of a 
hydroxyl stretching frequency in the IR. This did, however, contain the 
expected peaks arising from the pyrrole system. There was no evidence of the 
proposed alcohol in the fH NMR and integration in the region for the 
methylene envelope assigned six protons for this region, for the C(6 -8 )Hs. The 
13C NMR showed the expected pattern for the 1,2-disubstituted pyrrole, the 
remaining signals were consistent with the reduced pyrrole [282].
Scheme 45
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Decomposition meant that CHN measurements were inaccurate and so are 
not included in the experimental.
Ketone to methylene reductions have also been observed for sodium 
borohydride reduction of a seven-membered analogue [257],96 but reduction 
of the five-membered analogue [259] did stop at the alcohol stage.97 These 
results can be rationalised if it is assumed that the second step of the 
reduction (CHOH to CH2 ) proceeds via intermediate iminium ions [285].108 
In the case of the five-membered analogue [259], strain would prohibit 
formation of the iminium ion (Scheme 46).
The proposed intermediate [281] was not affected by the usual 
hydrogenation conditions with either catalyst. The other proposed 
intermediate [282] was partially reduced to the indolizidine [263] with both 
rhodium-on-alumina (no acid) and palladium-on-carbon (with H2SO4 ) but 
much more slowly than with the keto pyrrole [214] as substrate. Therefore 
neither of the proposed intermediates ([281] and [282]) are likely intermediates
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in the hydrogenation of the keto pyrrole [214] with either catalyst system. This 
conclusion differs from that of Breitner et a/.109 They carried out studies to 
compare Pt, Pd, Rh and Ru as hydrogenation catalysts. They found that in the 
reduction of mesityl oxide [286] to the saturated alcohol [288], reduction 
proceeded solely through the saturated ketone [287] (Scheme 47). The 
availability of the pyrrole lone pair to the conjugated system is clearly of 
significance.
The discovery that the pyrrole [282] was reduced to the indolizidine [263] 
much more slowly than the keto pyrrole [214], along with the discovery that 
an iminium ion is a probable intermediate in the facile reduction of the 
ketone [214] to the alcohol [215], led to proposition of the mechanism shown 
in Scheme 48.
With both catalysts, the first step is reduction of the ketone [214] to yield 
the alcohol [283]. This can undergo either reduction of the pyrrole to produce 
the hydroxy indolizidine [215] or elimination to produce the iminium ion 
[289], the latter subsequently being further reduced to produce the reduced 
indolizidine [263]. From the observed data it can be concluded that ki is 
greater with rhodium on alumina than with palladium on carbon. The rate 
of elimination k2  will be accelerated in the presence of acid. This hypothesis is 
consistent with the observations that mixtures of hydroxy indolizidine [215] 
and indolizidine [263] result both (a) when rhodium on alumina is used with
[286] [287] [288]
Scheme 47
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acid and (b) when palladium on carbon is used without acid. The higher rate 
ki with rhodium on alumina is consistent with the known reluctance of 
palladium to reduce aromatic systems.110
[214] [283] [215]
k2
It may be concluded that to selectively obtain the hydroxy indolizidine 
[215] it is necessary to maximise ki (i.e. use rhodium) and minimise k2  (avoid 
acid) whereas if the reduced indolizidine [263] is required one should 
minimise ki (use palladium) and maximise k2  (use acid).
A similar acid-catalysed elimination could be used to explain the different 
hydrogenation products of the tricycle [290] which, under palladium-catalysed 
hydrogenation gave the reduced[291] in the presence of acid and the alcohol 
[292] in the absence of acid (Scheme 49) .111
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[292]
The proposed intermediate [293] has a conjugated double bond and a non- 
conjugated double bond. The conjugated bond, being more susceptible to 
hydrogenation, would be reduced in situ yielding the hydrogenolysis product 
[291].
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2.9 Structural elucidation of Indolizidines.
2.9.1 Infra-red spectroscopy.
Figure 6 . NMR spectrum of Indolizidine [215].
Infra-red (IR) spectroscopy of the indolizidine [215], (Figure 6 ) showed an 
absorption at 3526 cm _1 that was attributed to a hydroxyl group. Another at 
1741 cm "1 was assigned as the C=0 stretch of the ester. It was therefore 
deduced that both the functionalities we required were in the molecule 
though their position had yet to be ascertained. IR also gives information on 
the fusion of the piperidine and the pyrrolidine rings. Although cis- and 
trans- fused hydrindanes ([294], [295]) (bicyclo[4.4.0]decane), the carbocydic 
analogues of the indolizidines, are well known,112 the cis- and trans- isomers 
of indolizidine [262] cannot be isolated, as rapid inversion of configuration at 
nitrogen interconverts them, produdng an equilibrium mixture (Scheme 50).
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A trans-linkage of the rings gives rise to Bohlmann bands113 in the I.R. 
spectrum.
[262a] [262b]
Scheme 50
The Bohlmann bands occur at ca 2800 cm and are brought about when two 
or more a-hydrogens are frans-diaxial to the lone pair on nitrogen. The 
spectra obtained show an absorption at 2807cm '1, thus indicating that the 
trans- [262b] is present, although this does not exclude the presence of the cis 
conformer [262a].
The fact that indolizidines are significantly more stable with a trans-ring 
fusion has been shown by modeling and by spectroscopic determination of 
-AG°, where Aaron et a/114 found that in 8 -hydroxyindolizidine, the total cis* 
fused population was only 4%. The free energy difference between the cis -and 
frans-fused conformers was -2.4 kcal m ol'l which indicates a strong 
preference for the trans conformation.
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2.9.2 NMR spectroscopy.
Basing their investigation on the IR data for the parent trans-fused 
indolizidine, Ringdahl et al 115 went on to prove the trans ring fusion from 
the 360 MHz NMR data. In comparing indolizidine with indolizidine 
hydrobrom ide (Figure 7), they used coupling constants from the spin- 
decoupled and expanded spectra to put forward the structure of a frans-fused 
ring system with a chair shaped piperidine and an envelope conformation for 
the pyrollidine ring, the nitrogen being displaced out of the plane formed by 
C(l), C(2), C(3) and C(9). This is in agreement with the X-ray crystallographic 
data of some indolizidine alkaloids investigated by Daly et al 26 with the 
carbon atoms 1,2,3 and 9 essentially coplanar (within ± 0.17 A) and the 
nitrogen atom puckered out of the ring [262]. Normally, the terms 'axial' and 
'equatorial' are used when discussing substituents in six membered rings 
indolizidine [262] has been drawn in such a way as to illustrate that the C(3)
4
substituents can be approximated to axial and equatorial though for those on 
C(l) and C(2) the labels a  and P are more appropriate (a being on the side of 
the nitrogen lone pair, P on the opposite) as they bisect the plane.116 The 
terms pseudo-equatorial and pseudo-axial are also commonly used.
[262]
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Figure 7. !H NMR spectrum on indolizidine (upper) and 
indolizidine hydrobromide (lower) in CDCI3 115
In our spectra of 5-methoxycarbonyl-8-hydroxyindolizidine [215] 
(Figure 8 ) the peak at 8  3.8 ppm integrates to one proton and has been 
assigned (using 1H, 13C, C-H correlation, COSY and NOE) as C(8 )H. It is an 
unresolved multiplet which appears as a broad singlet with a line width of 8 
Hz at half-height. Its shift upfield with respect to the C(8 )H resonance in the 
methylene envelope of the parent indolizidine is due to the hydroxyl group 
also on C(8 ). 3J couplings H-Hfrfl„s are of the order of 12-15 Hz, H-HCIS are of 
the order of 6 - 8  Hz. The proton on C(8 ) must therefore be equatorial to give 
all cis couplings as there are no couplings greater than 8  Hz in this multiplet. 
If this proton was axial then the 3J C(9)H-C(8)H and C(8)-C(7)Hax couplings 
would make the line width broader than the observed 8  Hz. As C(8 )H is 
equatorial then C(8 )OH must be axial giving the C(8 ) position the (Si- 
configuration
The singlet at 8  3.68 ppm integrates to three protons and was assigned to 
the methyl ester protons. The distorted triplet at 8  3.18 ppm is assigned as 
H(3)eq in accordance with the parent indolizidine.115 The absence of the
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H(5)eq resonance indicated that the 5-ester moiety was equatorial, not axial, 
the doublet of doublets at 8  2.8  ppm being assigned as H(5)ax- This was 
deduced in comparison with 5-cyanoindolizidine where the nitrile group 
(which has a similar effect on chemical shift to an ester group) was in an axial 
position and the H(5)eq had a shift of 8  4.66 ppm. A similar shift would be 
expected if H(5) were in fact equatorial in our case. The significantly upfield 
resonance at 8  2.8 ppm was assigned as H(5)ax. nOe measurements showed an 
nOe of 3.5% for the H(5)ax-H(9) interaction and 2.5% for the H (8 )eq -H (9 ) 
interaction. These observations therefore confirmed the 5(R), 8 (S) 
assignments. The other resonances of interest in (Figure 8 ) are the hydroxyl 
resonance at 8  2.52 ppm and the H (9) resonance bought out of the methylene 
envelope to appear at 8  2.21  ppm.
This information gives little or no indication of the conformations of the 
molecule. For this the spectrum of 5-ethoxycarbonylindolizidine [265] (Figure
i
9) was utilized. The equatorial proton H(3)eq appears as a doublet of triplets. 
The positions of the carbon atoms C(l) and C(3) are fixed if it is assumed that 
the piperidine ring is in a chair conformation.26 The pattern observed for 
H(3)eq suggests that the methylene hydrogens on C(2) and C(3) are nearly 
eclipsed and that C(2), C(3) and C(9) are virtually co-planar. The multiplicity 
can be explained as arising from the geminal coupling and coupling to one of 
the vicinyl methylene protons of a similar magnitude (ca 8  Hz), as well as a 
smaller coupling (2.6 Hz) to the other methylene proton.
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The axial proton H(3)ax, appears as a quartet indicating that the geminal 
and two vicinal coupling constants are of a similar magnitude. This can only 
arise if C(l), C(2), C(3) and C(9) are nearly co-planar. This gives dihedral angles 
between H(3)ax and the C(2) methylene protons of ca 30 and 150°. This is in 
good agreement with the assignments in indolizidine115 and X-ray data on 
Daly's indolizidine alkaloids.26
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3.1 Introduction
Having obtained the enantiomerically pure (5S,9R)-5-ethoxycarbonyl- 
indolizidine [265] and (5S,8S,9R)-5-ethoxycarbonyl-8-hydroxyindolizidine [264] 
the aim was to convert these substituted indolizidines to the required, natural, 5- 
alkyl indolizidines [212] and 5-alkyl-8-methyl indolizidines [213] as well as some 
simple analogues (Scheme 51).
As stated in Ing's 5-chain rule46, for muscarinic activity there should be 
five chain atoms linking a tertiary nitrogen and the chain terminus. This criteria 
is fulfilled with the 8 -methyl group on the indolizidine ring system. It was 
necessary to convert the 8 S hydroxyl group to the required 8 R methyl group. The 
obvious solution was to activate the alcohol with a moiety that would provide a 
good leaving group when an Sn2 attack of Me" was undertaken. This would 
invert the stereochemistry at C(8 ) yielding the desired 8 R methyl group. This 
methodology could also be applied to chain extension at the 5-position. A 
reduction of the 5-ester to the alcohol was envisaged, then activation of the 
alcohol as the tosylate followed by nucleophilic displacement with R-.
[265] [212]
[264] [213]
Scheme 51
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3.2. Manipulation of the 8-substituent.
3.2.1 Activation of the alcohol.
Nucleophilic substitution of hydroxyl groups requires prior activation of 
the C-O bond. Sulfonation is the most common approach used to achieve this. 
Alkane and arenesulfonic esters are important reagents in modern synthetic 
chemistry and are prepared from the corresponding sulfonyl chlorides and an 
alcohol.117 In general mesylates (methanesulfonic esters) are more reactive than 
tosylates118 (p-toluenesulfonic esters). The more recently developed triflates 
(trifluoro analogues) are even more reactive.119 The order of stability is 
Ts>Ms>Tf.
3.2.2 Grignard Reagents.
Grignard reagents have the advantage over organocuprates in that they 
are simpler to prepare. However, the scope of Grignard mediated reactions is 
much narrower than those involving the corresponding organocuprates. 
Grignard reagents couple only with activated halides (allyl and benzylic) and 
tosylates, with the aryl Grignard reagents giving superior yields compared to the 
alkyl. Grignards are tolerated by a number of functional groups, e.g. ethers, but 
will react with carbonyl and carboxyl groups to produce alcohols and ketones, 
respectively. As the compounds [264] and [265] contain the 5-ester functionality 
Grignard reagents would not seem to be ideal. Another consideration of 
Grignards is that where a tosyl group is present, often the elimination product 
rather than the desired substitution product results, for example [297] is 
produced from Grignard attack on [296] (Scheme 52).120
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[297]
3.2.3 Organocuprates.
Organocuprates are among the most versatile reagents in organic 
synthesis .121' 122 Indeed, copper is probably the most widely used of the 
transition metals in the field of organometallic and organic synthesis for the 
construction of C-C bonds.
M*Cu(l)Rj +
[300]
Scheme 53
The proposed mechanism for substitutions of halides and sulfonates is 
usually the direct displacement by R of R2CuLi. This fulfills the criteria of an Sn2 
type substitution (though an oxidative addition/reductive elimination 
mechanism is sometimes involved the reaction is still, overall, a substitution 
reaction) (Scheme 53) .123
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Tosylates124 and epoxides123 both react with organocuprates with 
inversion. More recent work has shown that not all halide displacements proceed 
with inversion of configuration at the carbon center125'126 This being the case, it 
would seem that tosylate is more reliable than halide as the species for our 
desired inversion at C(8 ) via the Sn2 substitution. Another advantage of the 
organocuprates is the relative inertness to other functionalities, especially 
towards esters (Scheme 54) .127 This is the case using either the catalytic Li2CuCl4 
species or the more widely used ’R2CuLi’ complex in stoichiometric amounts.
| - ^ ^ C 0 2 CH3  + UgCUCU -  ÇO2 CH3
MgCI
[301] [302] [303]
Scheme 54
Several syntheses have been undertaken in the alkaloid area with the 
strategy detailed above, viz. activation of the alcohol as a tosylate and 
displacement with a lithiocuprate, for example in the synthesis of 
perhydrogephyrotoxin [307] (Scheme 55).128
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[304] R=H ------- ► [305] R=Ts [306]
3.2.4 Results and Discussion. Activation of the 8-hydroxyl group.
Tosylation was first attempted under standard conditions, viz. tosyl 
chloride in dry pyridine.129 Surprisingly this only gave a yield of ca 20% of the 
tosylate [308] and recovery of starting material. Other conditions were tried, such 
as tosyl chloride in triethylamine, 130 and with catalytic amounts of DMAP (4- 
dimethylamino pyridine) .131 All of these conditions gave very low yields, so 
other activating groups were considered. Acetylation and triflation both failed 
giving no product or starting material, but base-line material on TLC (Scheme 
56).
To establish whether the failure of these reactions was due to low 
reactivity or steric hindrance of the alcohol, an attempt was made to alkylate and
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silylate with MOMC1 and tBDMSCl respectively. These reactions were selected as 
the products are protected alcohols which might be useful in further studies. 
Reaction of alcohol [215] with MOMC1132 yielded the MOM ether [312] in 25% 
yield (Scheme 56).
Molecular modeling showed that there should be no steric barrier to the 
protection of the 8-hydroxyl group. Indeed alcohol [215] did react with tBDMSCl 
to yield the protected alcohol [311], although the yield was again low (11%) 
(Scheme 56). Trimethylsilyl protection is discussed in section 3.2.5.
[309]
y<  AcjO.Pyr
MeO20 Me02C'
,OH NaH, TsCI, 
THF
2o% MeO20
,OTs
[310] [215] [308]
'BDMSCI, imidazol MOMCI, ('Pr)2NEl, DMF
[311] [312]
Scheme 56
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The low yields in the reactions of alcohol [215] with the various 
electrophiles was surprising, as Overman et al 128, in the synthesis of 
perhydrogephyrotoxin [307] and Holmes et a l48 in the synthesis of (-)-209B [76] 
found the mesylate to pose no problems. It is possible that the problems lay in 
the position of the alcohol group (3 to the tertiary nitrogen.
Another factor may be that the combined equatorial preferences of the 
ester substituent and the five-membered ring would force the tosyl group to be 
axial in a chair conformation (Figure 10), this being unfavourable. The 
problematic tosylation reaction will be further discussed in section 3.4.
3.2.5 Results and Discussion. tBDMSCl protection of the 8-hydroxyl 
group.
As well as the reaction of [215] with ‘BDMSCl (with imidazole in DMF)129 
to give the *BDMS protected alcohol [311], protection of the 8 -alcohol as the 
trimethylsilyl derivative, using TMSC1 and sodium hydride in THF as the solvent 
was attempted.130 This produced a white solid [313]. No hydroxyl peak was seen 
in the IR but the fH NMR did not correspond to what was expected. In 
particular, no TMS singlet was observed.
OTs
Figure 10. Tosyl activated indolizidine [308].
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3.2.6 Characterisation of the unknown compound [313].
The IR spectrum (Figure 11) showed that there was no hydroxyl group 
and that the carbonyl absorption had shifted from 1741cm"1 in the starting 
material to 1751 cm" 1 in the product. This is not a large difference but this, in 
combination with strong absorptions at 1270 and 1260 cm"1, indicated either an 
ester or a 5-lactone.
Figure 11. IR spectrum of unknown compound [313].
Integration of the NMR spectrum (Figure 12) and the number of 
resonances in the 13C spectrum gave a ratio of C:H of 9:13. This, coupled with the 
idea that lactonisation might have occurred led us to postulate the structure 
[313].
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[313]
The 13C DEPT spectrum (Figure 13) showed that there were five 
methylene and three methine carbons. From the 1H-13C correlation spectrum it 
was simple to assign the *H resonances at 8  3.27, 3.34 and 4.75 ppm as methine 
signals due to H(9), H(5) and H(8 ), respectively. As described in section 2.9.2 it is 
possible to distinguish equatorial and axial protons by the lack of significant 
coupling in the former. Thus, H(5) and H(8 ), which appear as broad singlets, 
must be equatorial whereas H(9), which is a partly resolved multiplet, is axial. 
This is important in confirming the tricyclic structure [313] which forces the 
piperidine ring into a boat conformation.
The resonance at 8  3.27 ppm was assigned as C (3)H ax and appeared as an 
apparent triplet. As in C (3)H eq of 5-ethoxycarbonyl indolizidine [265] the 
argument follows that the geminal and one of the vicinal couplings are of a 
similar magnitude, though in this case the second, smaller vicinal coupling is 
unresolved. The complex multiplet at 8  2.53 ppm is assigned as C (3)H eq and 
indicates, from its multiplicity, in conjunction with the resonance multiplicity for 
C (3)H ax, that the puckered envelope configuration of the pyrrolidine ring with 
the nitrogen out of the plane is no longer present. The rest of the methylene 
protons are contained in the multiplet 8  2 .1-1.6  ppm.
The high resolution mass spectrum and C,H,N analysis were also 
consistent with the proposed product [313].
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3.3 Manipulation of the 5-substituent,
3.3.1 Summary of M ethodology: H om ologation through  
activation/substitution.
There is literature precedent for the activation of hydroxyl groups with 
tosyl chloride and subsequent substitution using lithiocuprates. This 
methodology has been used in structurally related compounds including 
indolizidines.48 It was envisaged that application of this methodology would 
lead to the 5,8-disubstituted indolizidines.
Simple analogues of the natural products were also planned by varying 
the nature of the 5-ester group, as discussed in Section 3.3.4.
3.3.2 Results and Discussion. Side-chain hydroxyl group activation.
Ester [265] was first reduced to the alcohol [314] using LiAlH4  under 
standard conditions (anhydrous THF under an inert atmosphereXScheme 57) .131 
The alcohol [314] was isolated in 70% yield and required no further purification. 
Tosylation of the alcohol [314] was more problematic. No tosylate [315] was seen 
under standard conditions. Even with more forcing conditions using "BuLi as 
base, the tosylate [315] was only obtained in 26% yield. In view of the difficulty 
of obtaining the tosylate [315], bromination was instead attempted. However, 
reaction with CBr4 and PPh3132 led to a complex mixture of products and this 
route was therefore abandoned.
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As elimination products appeared to have resulted from the attempted 
synthesis of the bromide, activating groups which were more reactive than tosyl 
e.g. mesyl, triflate and nonanflate, were not investigated as it was thought that 
these would also readily eliminate. The low yields found in these reactions may 
be, as with the 8-hydroxyl group, due to the ^-position of the alcohol with respect 
to the tertiary amine, (see section 3.4).
3.3.3 Results and Discussion. C-5 chain extension.
t
Reaction of the tosylate [315] with lithiocuprates or Grignard reagents 
failed to produce the desired products. Instead work-up (saturated aqueous 
ammonium chloride and extraction with ether) yielded only starting material in 
all cases. The reaction was performed with both Me2LiCu and nBu2LiCu by 
addition of the lithiocuprate to a solution of the tosylate. The reverse addition 
was also investigated with the same result. Likewise, addition of a Grignard 
reagent to a solution of the tosylate resulted in only starting material being 
isolated.
During the reaction, there was indication that the lithiocuprate had 
formed due to the colour changes observed. A dark yellow precipitate was 
formed on addition of one equivalent of the alkyllithium to the copper (I) iodide 
and a deep green/black solution was formed upon the addition of the second
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equivalent. The Grignard reagent was taken from a fresh bottle ordered from the 
Aldrich Chemical company which contained no deposit of magnesium salts. 
Four equivalents of both the lithiocuprate and Grignard reagent were used at a 
temperature of -20 °C with reaction times in excess of 18 hours but none of the 
desired product was obtained. There are other examples of P-amino groups 
retarding coupling reactions in this way.133
Gmeiner134 undertook a similar substitution on a mesyl-protected alcohol 
P to a tertiary nitrogen [316] using Me2CuLi, Bu2CuLi and Ph2CuLi but 
published no yields. He later135 reported a reaction between a lithiocuprate and 
the mesylate [317]. Yields of only 47-48% were reported and only with 20 
equivalents of RLi and 11 equivalents of Cul at -20°C for 16 to 23 hours. Gmeiner 
et al gave no explanation for the sluggish nature of these reactions.
3.3.4 Results and Discussion. Synthesis of indolizidine analogues 
by transesterification.
Normal transesterification or alkoxy-de-alkoxylation can be catalysed by 
acids or bases, usually at high temperature.136 If acid or base-sensitive moieties 
are present in the molecule, transesterification can be undertaken at neutral pH, 
under mild conditions, for example by the use of iodotrimethylsilane, with 
catalytic amounts of iodine (Scheme 58).137 The ester is first O-silylated then the
CN
iMes
[316] [317]
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trimethyl silyloxy group is displaced by the alcohol [321] (which is the solvent in 
many cases).
r3oh
0
1
[319] 0  I
ü A i32ii r Ox
^ O R 2 •a
1R^X>R
[318] [320] [322]
Scheme 58
To avoid complications resulting from the hydroxyl functionality in 
building block [264] the transesterification studies were first carried out on the 
indolizidine [265]. Transesterification can be either acid- or base-catalysed. An 
acid-catalysed method would avoid base-catalysed epimerization at C(5) via the 
enolate [323] (Scheme 59).
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Scheme 59
The acid-catalÿsed transesterification of [265] produced only base line 
material. Therefore the reaction was attempted with the pyrrole [238]. If the ethyl 
group was replaced with a sterically more demanding group, the hydrogenation 
would proceed in a more diastereofacial fashion. To this end the ethyl ester a- 
ketopyrrole [238] was dissolved in isopropanol with catalytic quantities of 
concentrated HC1. No reaction occurred. A less sterically demanding alcohol was 
also used to test the reaction. Acid-catalysed methanolysis proceeded smoothly 
giving, after hydrogenation, 5-methoxycarbonylindolizidine [263](Scheme 60) 
with an [<x] d  comparable to that produced by our more direct route. This 
indicated that the transesterification had proceeded with retention of 
configuration at C(5).
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3.4 Discussion : the effect of p-amino groups on 
tosylation reactions.
To rationalise the low yields in the tosylation reactions, Hayworth's 
concept of ring conformation and 'neighbouring group effects' was 
considered.138 Isbell rationalised the formation of the 3,6-anhydro-P-methyl 
glucoside [327] from [325], originally reported by Peat and Wiggins,139 by two
successive Sn2  reactions, the first involving a tosylate displacement producing
*
the epoxide [326], the second generating [327] (Scheme 61).
Evidence for an intermediate aziridinium ion was presented by Tottathil et 
a/140 in the reaction of phenyl lithiocuprate with the pyrrolidine [328]. They 
found that the stereochemistry at C(4) was retained whereas in an Sn2 reaction, 
inversion would be expected. Their data indicated that the reaction was in fact 
two consecutive Sn2  reactions, the first step being an internal displacement of the 
tosylate group (Scheme 62).
[325] [326] [327]
Scheme 61
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They reasoned that the reaction could proceed via two separate pathways. The 
first, path a), proceeds via the aziridinium ion [329] in analogy to Wasserman's 
bicyclic aziridinone ion [333] (Scheme 63).141 Attack of the carbanion on [329] 
yielded the pyrrolidine [331]. In path b) the mechanism is thought to proceed via 
the bridged oxazinium ion [330] then on to the pyrrolidine [331]. Intra-molecular 
displacement by the lone pair on nitrogen to afford an aziridinium ion has also 
been postulated in the chemistry of castanospermine derivatives.142
[332] [333]
Scheme 63
[334]
Based on these ideas, an intermediate aziridinium ion [335] as the 
displacement product of the tosylate group may be considered. This can be in
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equilibrium with the tosylate [315]. Aqueous work up would yield the starting 
material [314] by attack of water on [335] (Scheme 64).
In the case of the 5,8-disubstituted indolizidine [264] there are, as in 
Tottathil's pyrrolidine [328], two possible displacement products, the aziridinium 
ion [337] from attack of the nitrogen lone pair displacing the tostlate of [336] 
(path a) and the bridged indolizidinium ion [338] from participation of the ester 
group of [336] (path b)(Scheme 65).
If simple models are made and the trajectory of attack considered (the 
concept of ’back-side attack') then these intermediates are not plausible in the 
case of the ester [336], though the ideas are valid with respect to the alcohol [314].
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A recent paper by Gmeiner et a l 135 found that a mesyl group p to the 
protected tertiary nitrogen in [339] was unstable. It could be 'characterised by 
immediately performed NMR spectroscopy' but soon rearranged via the 
intermediates [340] and [341] to give, after purification, the pyrrolidinium salt 
[342] (Scheme 66).
The isolation of the tricyclic lactone [313] as a crystalline solid (Section 3.2.5) can 
be rationalised by the intra-molecular attack of the alkoxide ion [343] on the ester 
functionality of [264] yielding [313] (Scheme 67).
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3.5 Summary.
A synthetic strategy has been devised to approach the naturally occurring 
5-mono and 5,8-disubstituted indolizidines [212] and [213] proceeding through 
the tosylates [315] and [308] respectively. In both these intermediates, the tosylate 
groups are p to the tertiary nitrogen. The synthetic problems which arose, viz. the 
low yields in the activation of alcohols as tosylates and the failure of nucleophilic 
substitutions at these sites both seem to be due to this P relationship. This 
suggests that alternative strategies must be developed involving only reactions in 
which a p-amino group will not interfere.
A possible alternative approach to the 5-side chain would be via Grignard 
reaction of ester [264], followed by a deoxygenation to yield compounds [212]. In 
summary, the ideas behind the activation/substitution approach have good 
literature precedent but, in our case, the P-nitrogen rendered it problematic.
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4.1 The ’Argiotoxins'.
4.1.1 Origins.
The interruption of glutamate-mediated neuromuscular transmission in 
invertebrates is a strategy employed by spiders for predation. The venom of 
spiders of the class Argiope (e.g. Argiope aurentia, an Orb weaver spider) contains a 
mixture of non-peptide toxins, low molecular weight 'argiotoxins' [344] (636), 
[345](659), [346](673), that have been found to be potent blockers of 
neuromuscular transmission both in insects143 and mammals.144
OH M e H
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H
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4.1.2 Biological Activity.
The glutamate receptors of the central nervous system of man and other 
mammals are believed to be involved both in the higher neural functions, such as 
memory and learning, and in neurological disorders e.g. hypoxemia, epilepsy, 
Huntington's, Alzheimer’s and Parkinson's diseases.145 Glutamate [347], as well 
as controlling the movement of insect skeletal muscle, is an active 
neurotransmitter in the mammalian brain. However, too much glutamate can 
cause brain damage. In the wake of a stroke or epileptic fit, the blood supply to 
the brain is reduced and glutamate levels build up. This overwhelms the 
enzymatic degradation of glutamate via y-amino butyrate [348](GABA), an 
inhibitory transmitter (Scheme 68), and the glutamate becomes 'excitotoxic', the 
constant excitement causing cell death.
glutamate
decarboxylase
h3V~— ^ c o 2
GABA-glutamate
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Scheme 68
It has been suggested by Jackson146 that the argiotoxin venoms are specific 
competitive inhibitors of the glutamate receptors, binding to them and thus 
denying access to the glutamate.
Neurobiological research, probing the structure and activity of sites of 
neurological interest, needs blockers of a high degree of specificity as 
pharmacological probes. Due to their specificity, argiotoxins would seem ideal
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for this purpose and could lead to structural elucidation of receptor sites and 
hence, perhaps, to treatments for neurological disorders.
4.1.3 Neurotransmission
Neurotransmission is the process by which a nerve cell passes on a signal 
to another nerve cell, muscle or gland. The structure of a nerve cell or neuron is 
shown in Figure 14.
Figure 14. Structure of a nerve cell.147
The neuron consists of a cell body, branched into dendrites for connection 
to other cells, and an axon. In man, the axon can vary in length from less than 1
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mm in the brain to almost 0.5 m in the spinal column (a factor of 10  ^longer than 
the diameter of the cell body). The axon is coated in a layer of lipid called the 
myelin sheath which acts as an electrical insulator. The difference between nerve 
cells and other cell types is that nerve cells are excitable.
All cells have a resting potential, a potential difference brought about by a 
difference in the concentration of ions inside and outside the cell. The cell 
membrane is selectively permeable to potassium and chloride ions, being 50-100 
times less permeable to sodium ions. All these ions move across the cell 
membrane through specific ion channels which span it. Excitation of the nerve 
cell is brought about by local changes in the concentration of ions causing Na+ to 
enter the cell. This leads to a depolarisation and a subsequent expulsion of K+ 
from the cell to attain the original resting potential. To attain the original state in 
terms of ion concentration, Na+ ions must be pumped from the cell (with 
concomitant entry of K+ ions to balance the charges).
The myelin sheath is an insulating layer but is not continuous, as indicated 
in Figure 14. The sodium and potassium channels are therefore only active in the 
gaps. This leads to an electrical impulse moving along the nerve from gap to gap 
as a wave of polarisation/depolarisation.
There is not a single nerve in the body long enough to connect the brain to, 
for example, the big toe so the message must be passed from neuron to neuron. 
There is no direct connection between neurons or between neurons and 
muscles/glands. At the junction between these, the electrical signal is converted 
into a chemical one in the form of a neurotransmitter which diffuses across the 
gap or 'synapse'. The neurotransmitter is released pre-synaptically and fits into a 
post-synaptic receptor, a glycoprotein of specific 3-dimensional structure. The 
neurotransmitter, due to its shape, fits into the receptor, triggering a new
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electrical impulse which moves down the next neuron and so on. The bound 
neurotransmitter is then either destroyed enzymatically or absorbed for future 
use.
Drugs and other xenobiotics that interfere with neurotransmission do so 
as either 'agonists' or 'antagonists' (Figure 15). Those that elicit a response are 
termed agonists, whereas those that bind to the receptor, thus denying the 
neurotransmitter access but eliciting no response, are termed antagonists.
Argiotoxins are glutamate antagonists. They bind to the glutamate receptor and 
deny the glutamate access. There are three major types of glutamate receptors:
• N-methyl D-aspartate (NMDA);
• quisqualate (AMPA);
/
• kainate.
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These classifications are based upon the receptor's response to agonists. 
Over the last few years, many NMDA antagonists have become available.148 
Sources of antagonists for quisqualate and kainate receptors seem to be the 
venoms evolved by predators of insects, whose neurotransmission is mediated 
by quisqualate-type receptors.
4.2 Argiotoxin analogues.
Argiotoxins have an internal polyamine chain flanked on one side by an 
N-terminal arginine and on the other by a hyroxyarylacetamide containing 
terminal asparagine. This arrangement of amino acids linked via a central 
polyamine is shown in Figure 16.
N-terminal arginine
/
polyamine
Figure 16. General structure of an Argiotoxin.
This general structure is also present in the related class, the 'nephilatoxins', of 
which there are three structural subclasses:
• JSTX
• NSTX
• NPTX
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4.2.1 JSTX nephilatoxins.
There is only one naturally occurring JSTX, viz. [351] JSTX-3. Analogues 2 
and 4 have been synthesised. Hashimoto149 noted the 'presence of a 2,4- 
dihydroxyphenylacetyl-aspariginyl cadaverine moiety'. This is elongated by a 8 - 
amino-4-azaoctanoic acid (putreanine) fragment.
4.2.2 NSTX nephilatoxins.
Once again there is only one naturally occurring example in the NSTX 
subclass, [352] NSTX-3.150 This contains Hashimoto's fragment, the putreanine 
fragment and terminates in N-terminal arginine.
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4.2.3 NPTX nephilatoxins.
Here there are four examples, 151 [353]-[356] bearing, at one end of the 
polyamine function an indole-3-acetyl containing terminal asparagine, the other 
end terminating either as the polyamine, or with N-terminal arginine.
, nh2
[355|
|356 ]
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In summary, the basic components of these classes of arachnid venoms are:
• an arylacetamide C-terminai group;
• a linking polyamine of varying structure;
• a terminal arginine (sometimes).
4.3 Chemical Syntheses.
Spider toxins of argiotoxin classes contain a variety of highly polar 
functional groups, aryl hydroxyl groups, numerous amines (primary, secondary, 
tertiary), and guanidine residues. All the syntheses to date make extensive use of 
standard protection/deprotection procedures, using the benzyloxycarbonyl 
(Cbz), tbutyloxycarbonyl (Boc) and benzyl (Bn) groups (Scheme 69).152
Although these protection-deprotection techniques are well documented 
and, in the main, high yielding, two steps are added to the synthesis for each 
protecting group used. In addition, use of some of these protecting groups are 
cost prohibitive on a commercial scale. There are also safety concerns with, for 
example, the use of the use of TFA. It would clearly be preferable to eliminate the 
need for protecting groups. What is therefore required is a system which can 
distinguish between the various, similar, functional groups. Enzymes achieve 
this by binding molecules in a highly specific manner. They place only one of the 
required groups into a catalytic environment, thus greatly accelerating reaction at 
that particular position.
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4.4 Enzymatic syntheses.
The number of steps in the synthesis of an argiotoxin could thus, in 
principle, be reduced by the use of enzymatic means to distinguish between the 
various nitrogen functionalities. Another advantage of enzymatic methods of 
synthesis is that mild conditions are used. This is particularly important with 
moieties such as tryptophan, which is particularly sensitive to acid and base.
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Polyamines are found in all higher organisms. They appear to be vital for 
regulating cell metabolism, though their exact function remains unknown.153 
Polyamines are polycationic at physiological pH and are closely associated with 
DNA in the nuclei of cells. Cells undergoing rapid turnover have been found to 
have elevated levels of polyamines. Polyamine metabolism in mammals is well 
documented . 154-155 It may be useful here to clarify the nomenclature and 
numbering system of polyamines Table 3.
Systematic name Trivial name Alternatives
1,4-Butanediamine Putrescine 1,4-Diaminobutane
N-(4-Aminobutyl)
acetamide N-Acetylputrescine
N-Acetyl-1,4- 
Diaminobutane
N-(3-aminopropyl)-l,4- 
butane diamine Spermidine -
N-{4-( (3-aminopropyl)- 
aminolbutyl) acetamide N®-Acetylspermidine Acetylspermidine A
N-{3-[(4-aminobutyD- 
aminolpropyl) acetamide N1 - Acetylspermidine Acetylspermidine B
N-4-(aminobutyl)-N- 
(3-aminopropyl) acetamide N4-Acetylspermidine -
Table 3
Numerical terminology is based on a modified aza-nomendature ( IUPAC Rule 
814.6), as convention requires the secondary nitrogen is assigned the lowest
number ( i.e. N4 rather than N5 ) as in Figure 17.
l
n h 2
[363]
Figure 17. Numbering system of polyamines.
1. Ornithine decarboxylase.
2. Spermidine synthase.
3. Spermine synthase.
4. Spermidine/spermine synthase.
5. Polyamine oxidase.
6. Spermidine N-acetyl 
transferease.
7. N-Acetyl spermidine
deacetylase.
Scheme 70
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As can be seen from the metabolic pathway scheme (Scheme 70),154 there 
are two possible ways of enzymatic differentiation between N1 and N8;
• selective hydrolysis;
• selective acylation.
4.4.1 Selective Hydrolysis.
Marchant156 showed that the metabolic fates of -acetylspermidine and 
N^-acetylspermidine are different in vivo, as shown in Scheme 70. N *- 
acetylspermidine undergoes oxidative cleavage by polyamine oxidase to yield 
putrescine whilst N^-acetylspermidine, under the influence of N - 
acetylspermidine deacylase yields spermidine and acetic acid. N-Acetyl 
spermidine deacylase was first discovered by Libby in calf liver157 and by 
Blankenship in rat liver.158 Further work by Marchant et al showed that N1- 
acetylspermidine did' not undergo deacetylation by N-acetylspermidine 
deacylase (using rat liver cytosol fraction) whilst N8-acetylspermidine did. The 
differentiation of N^- verses N®-acetylspermidine would seem to be due to a 
highly specific active site in the N1-acetylspermidine deacylase. Dredar et al, 
from their work on inhibitors of N®-acetylspermidine, proposed the bonding 
interaction scheme for the active site shown in Figure 18.154 Thus, the N1- 
acetylspermidine does not fulfill the steric/electronic demands of the active site 
and so is not deacetylated.
4.4.2 Selective Acetylation.
Cells contain cytoplasmic enzymes capable of converting spermine to 
spermidine and spermidine to putrescine. Both these are two-step processes via 
Nl-acetyl derivatives of spermine and spermidine respectively159-160. In 
addition, there is a nuclear enzyme that acetylates spermidine selectively at the
132
N8 position. However, N^-acetylspermidine is not seen in appreciable quantities 
in most tissues due to the probable action of a cytoplasmic enzyme that 
selectively deacetylates N8 -acetylspermidine156. It can be inferred both from 
these results and from the pathway proposed in Scheme 70 that it is possible to 
distinguish between the N^-and N®-acetyl groups on spermidine by the action of 
these rat liver cell fractions.
lipophilic [KH-ki-l lo r Cl In
4.4.3 Single enzyme preparations.
Cytosolic fractions of animal tissues contain a mixture of enzymes. In 
many cases it is more informative and practically more efficient to use 
commercially available single enzyme preparations. These 'solid' enzyme
preparations are of greater use than the aqueous cytosolic fractions in systems
/
where the solubility of the substrate in water is not significant. Their use in these
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'lipophilic' systems requires a more imaginative and inventive approach to 
conditions, solvents etc.
4.5 Enzymes in organic solvents.
As early as 1937 Bergman and Fraenkel-Conrat161-162 suggested that the 
reversibility of protease catalysed reactions could be utilised for the formation of 
peptide bonds. During the past decade such enzymatic catalysis has attracted 
much attention. This has led to the development of many systems that 
successfully attain enzymatic activity in predominantly organic media. These 
include the direct suspension of enzyme particles in the organic phase, covalent 
modifications to render the enzyme soluble in organic solvents and the use of 
biphasic media as well as water miscible organic solvents. All these have their 
advantages and disadvantages, though so far a direct comparison of enzymatic 
stability and activity has not been possible.
4.5.1 Anhydrous organic solvents.
The use of lipases and proteases in essentially anhydrous solvents has 
received much attention.163-164'165 The range of reactions (Scheme 71) includes: 
general amide synthesis166 using various biocatalysts in hexane and the 
production of amides enantioselectively167'168 and transesterification169 using 
such media such as hexane, 1,4-dioxane, or diisopropyl ether. N-Acetylations, 
however, are rarer than O-acetylations and have mostly been used in the field of 
peptide synthesis.170 N-Acetylation has been accomplished for primary165-171 
aromatic172 and secondary amines173 using ethyl acetate as both solvent and 
transfer reagent.
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Scheme 71
Surprisingly, even hydrolysis can be performed in "anhydrous" 
diisopropyl ether.174 Kanerva and Klibanov175 undertook mechanistic studies 
using Subtilisin carlsberg as a model as it had been shown to have protease 
activity in anhydrous organic solvents. They concluded that there were 
"profound" mechanistic similarities in organic media and aqueous media. This 
suggested that the transition state in both media is essentially the same.
4.5.2 Biphasic systems
Numerous groups have achieved the synthesis of peptides in two-phase 
reaction mixtures,176 viz. an aqueous phase (containing the enzyme) and a water- 
immiscible organic phase. The equilibrium is shifted due to the preferential 
solubility of the peptide formed in the organic phase with respect to the starting 
material. The main limitation of the biphasic system seems to be biocatalyst 
stability, which often results in the precipitation of the enzyme as a gel. Hailing 
showed that biocatalyst stability increased as the polarity of the solvent 
decreased.177
Many groups have investigated the use of water miscible co- 
solvents178' 179 and the changes they induced in the catalytic activity of a -
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chymotrypsin and laccase. The best co-solvents were found to be the 
polyalcohols ethylene glycol and glycerol (in which a-chymotrypsin inactivation 
is reversible). The reasons proposed for the changes in catalytic activity of the 
biocatalysts178'180' 181 in these systems are summarised below:
• some organic co-solvents (and water) may act as substrates for, and thus 
competitive inhibitors of enzyme activity;
• the co-solvent may act as a specific inhibitor;
• addition of a co-solvent changes the bulk properties of the solution, thus 
changing the interactions between, enzyme, substrate and solution;
• the co-solvent may denature the enzyme.
Mozhaev et al produced a quantitative correlation of denaturing ability vs. 
hydrophobicity.178 This points to the general rule that the best co-solvents are the 
most hydrophilic ones; The authors add a cautionary note that this relationship 
can only be applied to organic solvents with the same homological group.
Enzymes have been covalently modified by the attachment of 
polyethylene glycol residues.182 This rendered the enzyme soluble in benzene 
both for peptide formation and hydrolysis. This was found to be quite 
satisfactory, the catalytic activity of the enzymes being only three to four fold 
lower than in aqueous buffer. Reasonable evidence was found that the enzyme 
structure is more compact in water restricted environments, limiting 
conformational mobility. Another interesting discovery was that the minimum 
amount of water required for enzymatic activity in anhydrous organic media 
was ca 0.04%, the optimum being 0.09% (by volume).183 Enzymes in 'anhydrous' 
systems, require a minimum amount of water to maintain their shape and remain 
active. The conformation of an enzyme is maintained by hydrogen bonds and 
salt bridges. All organic solvents will allow a certain amount of water to dissolve
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in them. If this is not present then the water maintaining the shape of the enzyme 
will dissolve in the solvent and the enzyme will be denatured and thus 
deactivated.
4.5.3 Emulsions.
The final way to overcome poor solubility of organic reagents in aqueous 
systems or to maintain favourable equilibrium changes is to use oil-in-water 
emulsions containing for example, non-ionic surfactants. Hughes et a/,184 in the 
enzymatic hydrolysis of dithioacetal esters (Scheme 72) using lipase from 
Pseudomonas sp., found hydrolysis occurred very slowly.
lipase
^ ^ conm«2 ^ - ^ ^ C O N M e 2
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Scheme 72
This was attributed to the presence of a liquid-solid interface produced by 
the insolubility of the esters, so Triton X-100 was used to aid their solubility. It 
was found that the addition of water-miscible solvents such as DMF, ethanol and 
2-propanol decreased the already sluggish rate of hydrolysis. So, in cases where 
the optimum organic co-solvent proves elusive the addition of Triton X-100 or
other surfactants (though X-405 and X-705 were in this case less effective) 
provides another approach.
In summary, the precedent of the known metabolism of polyamines may 
be put forward as proof that enzymes are capable of differentiating the N-1 and 
N-8  termini of spermidine. This should allow selective protection of one end of 
the polyamine, or selective deprotection of a fully protected molecule, in order to 
begin the construction of one of the argiotoxins.
4.6 Summary of new methodology.
It was decided to start with the deprotection of a fully protected 
spermidine model. The model system chosen was 1,4-diaminobutane [365] and 
the protecting group was benzyl formate (Cbz) (Scheme 73).
[377]
CbzHN
NHCbz
[378]
Scheme 73
The intention was to selectively deprotect one of the protected amines, to 
derivatise this free amine and then to use catalytic hydrogenation to remove the 
other Cbz group. The Cbz protecting group was particularly appropriate, as it is 
hydrolysed by a range of enzymes including proteases, amidases and lipases 
which cleave different bonds in the molecule (Figure 19). In the case of lipases a 
decarboxylation reaction would be expected to follow to yield the free amine. 
The use of acetate derivatives was also considered, as acetate is one of the more
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commonly used protecting groups.
lipase
protease,
amidase
Figure 19. Enzymatic cleavage of the benzyl chloroformate protecting group
Model compounds [379] and [378] were prepared from diaminobutane 
under standard conditions. 185,186 The structures were confirmed by ^H , 13C 
NMR and mass spectrometry. The protected spermidine derivatives [380] and 
[381] were prepared by the same methods. The tris Cbz compound [381] was 
easily characterised by and 13C NMR but the tris acetyl derivative [380], 
although apparently pure by TLC and MS, showed two sets of closely spaced 
resonances in both its fH and 13C NMR spectra. This phenomenon can be 
attributed to restricted rotation about the tertiary amide bond in [380]. Indeed, on 
warming to 337 K the signals were seen to coalesce. This feature has also been 
observed by Ohtani et al investigating the conformation of Ptilomycalin A [382]
4.7 Preparation of substrates
n h 2 NHCbz
CbzHN'
[379] [378]
NHAc NHCbz
Ac Cbz
[380] [381]
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using trifluoroacetylated spermidine analogues.187 The data they produced is 
very similar to ours and confirmed our assignments of the 'H NMR spectra.
4.8 Results and discussion.
*
A variety of enzymes and solvents were employed in the attempt to 
deacylate bis(Cbz)-l,4-diaminobutane [378] and tris(Cbz)spermine [381]. For 
amidation and hydrolysis of the peptide bond a variety of enzymes may be used, 
not only amidases and proteases but also lipases.188-189 Both the reactions 
proceed via an [enzyme-acyl] intermediate [383] and, depending on the next step, 
either the hydrolysis [384] or the peptide product [385] may be formed as in 
Scheme 74. The hydrolysis of an amide can be achieved in an aqueous system.
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Substrate Solvent Enzymes Result
[378] Buffer a ,  ß  - C h ym otryp sin no reaction
[378] 10% DMF P6 , CCL,
a ,  ß  - C h y m o tryp sin
no reaction
[378] 10% acetonitrile P6 , CCL,
a, ß - C h y m o tryp sin
no reaction
[378] 10% ethylene 
glycol
P6 , CCL,
a, ß - C h y m o tryp sin
no reaction
[378] dichloromethane P6 , CCL, PN, PS
a, ß - C h ym otryp sin
no reaction
[378] hexane P6 , CCL,
a ,  ß - C h y m o tryp sin
no reaction
[378] Buffer/Triton X- 
100
P6 , CCL,
a ,  ß - C h y m o tryp sin
no reaction
[381] Buffer P6 , CCL,
a ,  ß  - C h y m o tryp sin
no reaction
[381] 10% DMF P6 , CCL,
a ,  ß  - C h y m o tryp sin
no reaction
[381] 10% ethylene 
glycol
P6 , CCL,
a ,  ß -  C h y m o tryp sin
no reaction
Table 4. Attempted hydrolysis of Cbz protected polyamines.
Buffer = Tris HCl, pH 7.8 
P6 = Amano Protease '6'
PN = Amano Protease 'N'
PS = Amano Protease 'S'
CCL -  Candida cyclindracae. lipase
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Enzyme R " ^ O H
[386]
[383] [384]
R"NH2
1
FT NHR*
[385]
Scheme 74. Enzyme-acyl intermediate.
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Substrate Solvent Enzymes Reaction
[380] Tris HC1 Buffer P6 No reaction
[380] Tris HC1 Buffer PS No reaction
[380] Tris HC1 Buffer PN No reaction
[380] Tris HC1 Buffer CCL No reaction
[380] Tris HC1 Buffer Pronase No reaction
[380] Tris HC1 Buffer Acylase 1 No reaction
[380] Tris HC1 Buffer PPL No reaction
Table 5. Attempted hydrolysis of acetate protected polyamines
P6 = Amano Protease '6'
PN = Amano Protease 'N'
PS = Amano Protease 'S'
CCL = Candida cyclindracae. lipase 
PPL = pig pancreatic lipase.
Many different solvents have been used successfully with enzymatic 
activity being retained. The solvents chosen were selected by following literature 
precedents. From Tables 4 and 5 it can be seen that the organic solvents used 
were dimethyl formamide, acetonitrile and ethylene glycol (as water soluble 
solvents) and that hexane and dichloromethane were used in the reactions 
requiring biphasic or virtually anhydrous conditions. Schneider et al reported at 
the T993 Biotransformations Update', the effect of solvents on lipase activity 
(Figure 20), indicating that in hydrophobic solvents such as hexane and toluene 
the enzyme retains almost all its activity with respect to an aqueous system.190 
This was also reported earlier by Klibanov191 who rationalised this observation 
by proposing that the more hydrophilic solvents 'strip' essential water (see later) 
from the enzyme molecule thus diminishing enzymatic activity.
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Though this data is for lipase activity, the presence of the common acyl- 
enzyme intermediate allows us to propose this will be the case for other classes 
of enzyme.
In water reduced systems (dichloromethane, hexane) the enzymes were 
lypholysed prior to use. This involves the dissolution of the enzyme in an 
appropriate pH buffer (in our case pH 7.8) and subsequent removal of the water 
by freeze-drying. This satisfies two of the three criteria for enzymatic activity in 
organic solvents.191
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Figure 20. The effect of solvents on lipase activity.
Freeze-drying maintains a mono-layer of water molecules over the enzyme, thus 
the hydrogen-bonds and other forces that maintain ternary structure in the
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enzyme remain, thus defining the shape and subsequent bioactivity of the active 
site. The second criterion, is that of 'pH memory' of the enzyme. The enzyme 
'remembers' the pH of the last water it came into contact with through the 
charged groups at the active site. These are maintained at the pH of the buffering 
solution. This will affect (again) the overall shape of the active site and also the 
'fit' of charge sensitive groups in the substrate. The third criterion, that of the 
enzyme 'suspension' being composed of as small as possible particles to increase 
the surface contact of the enzyme and substrate solution was fulfilled by 
vigorous stirring. Samples were taken directly from the stirred suspension, 
partitioned between ethyl acetate and water and both solutions applied to the 
TLC plate for analysis.
Lypholysed enzyme was also used for the buffered aqueous solutions and 
those that contained co-solvents for direct comparison and they were also 
vigorously stirred. Samples were taken, as above, from the stirred solution, 
partitioned between ethyl acetate and water and both organic and aqueous layers 
analysed by TLC.
As can be seen in Table 4, the benzyloxycarbonyl protecting group seems 
to be resistant to enzymatic cleavage under the many conditions tried. Others 
have also found this.192 This result may be rationalised by the donation of 
electron density to the carbonyl carbon due to the dipole effects of the groups 
present. This decreases the electrophilicity of the carbonyl carbon (Figure 21).
Figure 21. Donation of electron density to the carbonyl carbon 
of the benzyloxycarbonyl group.
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The other possible reason for the failure to cleave the benzyloxycarbonyl 
group is bad fit/no fit in the active site of the enzyme involved. The lipophilic 
nature of the substrate means that methods using enzymes in low-water 
systems/biphasic systems must be used. The active site of enzymes in organic 
media are substantially the same as in aqueous media though it seems 'tighter' in 
water-restricted environments. This will have the effect of increasing the 
specificity of the enzyme, thus an enzyme that has a wide spectrum of substrates 
in aqueous media will have a substantially reduced range in organic media. 
Though this may be a contributing factor, others have successfully cleaved large 
groups enzymatically, for example the lipase catalysed cleavage of P- 
naphthols.193 This led us to believe that the 'deactivation' of the carbonyl carbon 
is the dominant factor in the inability of the enzyme to cleave the 
benzyloxycarbonyl group under the conditions we tried.
Another possible contributing factor to the lack of activity could be a 
stable acyl-enzyme intermediate. This would account for the TLC observation 
that only baseline material and starting material were seen. If there was a stable 
acyl-enzyme intermediate then the baseline material would be enzyme and 
bound starting material.
Polyamine-polynucleotide interactions are well documented,194'195'196 this 
has even been seen for anthracyl derivatives with DNA helices.197 Polyamine- 
protein interactions have also received attention, though in both, the exact 
interactions are often hard to decipher due to many non-specific interactions 
which tend to mask the specific ones. Polyamines have been found to be potent 
alosteric regulators of enzymes e.g. acetylcholinesterase198 as well as of NMDA- 
type glutamate receptors.199 Workers have found that though the number of 
charges on the polyamine were thought to be the major contributing factor to
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binding (spermine>spermidine>putrescine; charged groups, 4, 3, 2 respectively) 
there are other factors at work. Indeed N1 and N8-acetylspermine both had a 
higher affinity to DNA than expected,200 clearly there were non-electrostatic 
effects present.
To test the idea of the electron donating effect of the Cbz group being the 
major deactivating force on enzymatic cleavage, we decided to look at other 
derivatives. We began looking at the phenyl acetyl derivative [388] due to the 
fact that only one functional group can significantly donate electron density to 
the carbonyl group. We also chose the N-phenylaminothio carbonyl derivative 
[389] for investigation to determine the effect of changing nature of the 
heteroatoms, incorporating nitrogen and sulfur instead of oxygen.
The cyano derivative [390] was prepared201 with a view towards comparison to 
the triacetylated spermidine and the beginnings of investigations into non- 
electrostatic interactions to see if a stable acyl-enzyme derivative was being 
formed .
[389]
4.9 Summary.
Previous work on in vitro enzymatic acetylations / deacetylations had 
shown that some enzymes (see Scheme 70) are capable of differentiating between 
the N1 and N8 positions of spermidine. The proteases and lipases we chose, 
under our conditions (Tables 4 and 5), did not seem to have the required activity. 
This could be due to the electron rich nature of the carbonyl group of the Cbz 
protecting group, which we had chosen as the proposed deprotection method 
(catalytic hydrogenation) is both simple and relatively environmentally friendly.
The acetamide group should have been hydrolysed by the enzymes we 
used, if only nonselectively. The enzymes in Table 5 were chosen as they have 
been used widely in the area of biotechnology on a broad range of substrates. We 
thus have no explanation for the failure of these reactions.
Work on this project ceased due to the unfortunate death of Dr. D. W.
Hutchinson.

5.1 Introduction.
Melting points were determined using a Stuart Scientific SMP 1 melting 
point apparatus and are uncorrected. Optical rotations were recorded on an 
Optical Activity Ltd model AA-1000 polarimeter at 589 nm (Na D-line) with a 
path length of 2 dm. Concentrations (c) are quoted in g/100 ml. Microanalyses 
were performed by Mr. Paul Moore, University of Warwick on a Leeman 
CE440 elemental analyzer. Infra red spectra were recorded neat, in solution, or 
as nujol mulls, as indicated, on a Perkin-Elmer 1720X fourier transform 
spectrometer using sodium chloride plates. Only selected absorbances (vmax) 
are reported. NMR spectra were recorded at either 250 MHz, 300 MHz, or 
400 MHz on Bruker ACF 250, Varian Gemini 300 MHz, or Bruker ACP 400 
instruments respectively. Chemical shifts (8h ) are quoted in parts per million 
(ppm), referenced to the appropriate residual solvent peak. Coupling 
constants (/) are reported in Hertz. 13C NMR spectra were recorded at 63 MHz 
on a Bruker ACF 250 instrument unless stated otherwise. Chemical shifts (8c) 
are quoted in ppm, referenced to the appropriate solvent peak. Low resolution 
mass spectra and some high resolution mass spectra were recorded on a 
Kratos MS 80 spectrometer with only molecular ions (M+) and major peaks 
being reported with intensities quoted as percentages of the base peak. Other 
high resolution mass spectra were recorded on a VG Analytical ZAB-E 
instrument. Chemicals were purchased from Aldrich, Fluka or Sigma at the 
highest available grade. All solvents were purchased from Fisons Scientific 
Equipment at SLR grade and purified, when required, by literature 
methods202. Anhydrous solvents were obtained as follows; CH2CI2, distilled 
from calcium hydride under nitrogen; THF, distilled from sodium- 
benzophenone under nitrogen; C6H6 , distilled from sodium hydride under 
nitrogen; MeOH and EtOH, distilled from magnesium methoxide and 
magnesium ethoxide respectively under nitrogen. TLC was performed on
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glass backed plates pre-coated with silica (0.2 mm, 6 OF254) which were 
developed using one or more of the following agents; UV fluoresence (254 
nm), iodine vapour, potassium permanganate solution (0.5 % v/v)/A,  
sulfuric acid solution (8  % v/v)/A,  ammonium molybdate (2.5 % w/v) and 
CeSC>4 (1.0 % w/v))/A or ninhydrin/A. Flash chromatography was performed 
on silica gel (Merck Kieselgel 6OF254, 230-400 mesh). Petroleum ether used in 
flash chromatography was of the boiling range 40-60°C unless otherwise 
stated. The drying reagent used was MgSC>4 unless otherwise stated.
5.2 Experimental details for Chapter 2.
2-Pyrrol-l-ylpentanedioic acid [225]. To a solution of (L)-glutamic acid [211] 
(10.16g, 6.9 x 10"2 moles) in glacial acetic acid (250 ml) containing sodium 
acetate (17.5g) at 85°C was added 2,5-dimethoxytetrahydrofuran [223] (9 ml, 8.28 
x 10'3 moles, 1.2 equiv) dropwise. Stirring was continued for a further 10 min 
and the deep red solution was cooled to room temperature and poured into 
water (300 ml). Diethyl ether (400 ml) was then added, the aqueous layer 
separated and extracted with diethyl ether (400 ml). The combined organic 
layers were then evaporated in vacuo to yield a brown residue. 
Dichloromethane (300 ml) was added, precipitating out a brown solid which 
was filtered off. The remaining yellow solution was then dried (MgSC>4) and 
evaporated in vacuo to yield [225] as a yellow oil (3.38g 24.8%); [a ]“ -42.9° (c 
3.0, MeOH); VniaxineatJ/cm' 1 3416(m), 1578(s), 1550(m); 8 *h  (250 MHz; D2O) 
6.79(2H, m, a-pyrrole protons), 6.14(2H, m, |}-pyrrole protons), 4.46(1H, dd, 
J=10.0,9.3 Hz, C(5)H), 2.32-1.98(4H, m, 2 x CH2) 8c  (CDCI3) 177.91,177.46,175.93, 
61.73,30.91, 27.10,21.21; m/e (NH3, CI+) 198(MH+)(100%).
2-Pyrrol-l-ylpentanedioic acid dimethyl ester [224] (Method A). To a solution 
of (L)-glutamic acid dimethyl ester hydrochloride [222] (8.62g, 0.04 moles) in
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glacial acetic acid (250 ml) containing sodium acetate (20.22g) at 85°C was 
added 2,5-dimethoxytetrahydrofuran [223] (5.2 ml, 0.048 moles, 1.2 equiv) 
dropwise. Stirring was continued for a further 30 min and the deep red 
solution was cooled to room temperature and poured into water (300 ml). 
Dichloromethane (200 ml) was then added, the aqueous layer was separated 
and extracted with dichloromethane (2 x 100 ml). The combined organic layers 
were then dried (MgSC^) and evaporated in vacuo to yield a red oil which was 
purified by Kugelrohr distillation to yield [224] as a colourless oil (4.34g 48%); 
(Found: C, 58.74; H, 6.64; N, 6.09%, C11H15NO4 requires C, 58.66; H, 6.71; N, 
6.22%); [a]„ -28.6° (c 1.32, MeOH); VmaxfneaO/crn-1 1735(s); 5r  (250 MHz, 
CDCI3) 6.70(2H, t, J=2.2 Hz, a-pyrrole protons), 6.17(2H, t, J=2.2 Hz, ^-pyrrole 
protons), 4.80(1 H, dd, J=10.0, 9.3 Hz, C(5)H), 3.72(3H, s, CO>Me). 3.65(3H, s, 
C 0 2Me), 2.50-2.12(4H, m, 2 x CH2); 5 c  (CDCI3) 172.51, 170.54, 119.89, 108.62, 
60.24, 52.20,51.35, 29.32,27.83 ; m/e (NH3, CI+) 226(MH+, 100%).
2-Pyrrol-l-ylpentanedioic acid dimethyl ester [224] (Method B). To a solution 
of (L)-glutamic acid dimethyl ester hydrochloride [222] (1.64g, 7.7 x 10~3 moles) 
in water (80 ml) at 70°C was added 2 ,5 -dimethoxytetrahydrofuran [223](1.2 ml, 
9.26 x 10'3 moles, 1.2 equiv) dropwise. Stirring was continued for a further 30 
min and the deep red solution was cooled to room temperature. 
Dichloromethane (100 ml) was then added, the aqueous layer was separated 
and extracted with dichloromethane (2 x 50 ml). The combined organic layers 
were then washed with dilute HC1 (200 ml), water (200 ml) and brine (100 ml), 
dried (MgSC>4 ) and evaporated in vacuo to yield a red oil, which was purified 
by Kugelrohr distillation (130°C, 0.2 mm Hg) to yield [224] as a clear oil (1.36 g, 
70%); [a]“ -33.5° (c 1.70, MeOH). Other spectral features were identical to [224] 
produced by method A.
2-Pyrrol-l-ylpentanedioic acid diethyl ester [227] (Method A). To a solution of 
(L)-glutamic acid diethyl ester hydrochloride [226] (8.62g, 0.04 moles) in glacial
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acetic acid (250 ml) containing sodium acetate (20.22g) at 85°C was added 2,5- 
dimethoxytetrahydrofuran [223] (5.2 ml, 0.048 moles, 1.2 equiv) dropwise. 
Stirring was continued for a further 30 min and the deep red solution was 
cooled to room temperature and poured into water (300 ml). 
Dichloromethane (200 ml) was then added, the aqueous layer separated and 
extracted with dichloromethane (2 x 100 ml). The combined organic layers 
were then dried (MgSC>4) and evaporated in vacuo to yield a red oil which was 
purified by Kugelrohr distillation to yield [227] as a colourless oil (8.43g, 83%). 
(Found C, 61.85; H, 7.51; N, 5.53%; C13H19NO4 requires C, 61.66; H, 7.51; N, 
5.53%; [a]“ -16.6° (c 1.06, EtOH); v^ n caO / cnr* 1738(s);81h  (250 MHz, CDCI3) 
6.71 (2H, t, J=2.1 Hz, a-pyrrole protons), 6.17(2H, t, J=2.0 Hz, (3-pyrrole protons), 
4.70(1H, dd, J=5.5, 9.7 Hz, C(5)H), 4.18(2H, q, J=6.9 Hz, CO2CH2CH3), 4.1(2H, q, 
J=6.9 Hz, CO2CH2 CH 3 ), 2.47-2.10(4H, m, 2 x CH2), 1.25(3H, t, J=6.9 Hz, 
CO2CH2CH3 ), 1.24(3H, t, J=6.9 Hz, CO2CH2CH3 ); 8c  (CDCI3) 172.25, 170.18, 
119.94, 108.87, 61.55, 60.61, 60.52, 29.80, 27.92, 14.04, 13.96; m/e (NH3, CI+) 
254(MH+, 60%) [Found, 254.1392(MH+), C13H20NO4 requires 254.1387].
2-Pyrrol-l-ylpentanedioic acid diethyl ester [227] (Method B). To a solution of 
(L)-glutamic acid diethyl ester hydrochloride [226] (1.64g, 7.7 x 10'3 moles) in 
water (80 ml) at 70°C was added 2,5-dimethoxytetrahydrofuran [223] (1.2 ml, 
9.26 x 10‘3 moles, 1.2 equiv) dropwise. Stirring was continued for a further 30 
min and the deep red solution was cooled to room temperature. 
Dichloromethane (100 ml) was then added, the aqueous layer was separated 
and extracted with dichloromethane (2 x 50 ml). The combined organic layers 
were then washed with dilute HC1 (200 ml), water (200 ml) and brine (100 ml), 
dried (MgSC>4) and evaporated in vacuo to yield a red oil, which was purified 
by Kugelrohr distillation (130°C, 0.2 mm Hg) to yield [227] as a clear oil (1.36 g, 
70%); [a]“  -22.1° (c 1.12, EtOH). Other spectral features were identical to [227] 
produced by method A.
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2-Pyrrol-l-ylpentanedioic acid dimethyl ester [224] (Method C). To a solution 
of [225] (3.25g, 0.016 moles) in dry methanol (200 ml) was added Amberlyst 
A15 (5g). The mixture was refluxed under nitrogen for 48 h, cooled and the 
resin was removed by filtration. The methanol was removed in vacuo to 
yield a brown oil (2.54g). The crude product was purified by column 
chromatography (EtOAc:Pet ether, 1:2, Si02) to yield [224] as a colourless oil 
(1.62g, 44%); [a]“ -29.9° (c 1.33, MeOH). Other spectral features were identical 
to [224] produced by method A.
2-Pyrrol-l-ylpentanedioic acid diethyl ester [227] (Method C). To a solution of 
[225] (3.25g, 0.016 moles) in dry ethanol (200 ml) was added Amberlyst A15 
resin (5g). The mixture was refluxed under nitrogen for 48 h, cooled and the 
resin was removed by filtration. The methanol was removed in vacuo to 
yield a brown oil (3.32g). The crude product was purified by Kugelrohr 
distillation (150°C, 0.2 mm Hg) to yield [227] as a colourless oil (2.35g, 52%); 
[<x ] d 20 -17.0° (c 1.12, EtOH). Other spectral features were identical to [227] 
produced by method A.
4-Pyrrol-l-ylbutyric acid [254]203 (Method A). To a solution of 4-aminobutyric 
acid (15g, 0.146 moles) in acetic add (350 ml) containing sodium acetate (75g, 
0.915 moles) at 80°C with stirring was added 2 ,5 -dimethoxytetrahydrofuran 
(19.2g, 0.146 moles) dropwise over a period of 5 min. After a further 15 min 
the reaction mixture was diluted with water (850 ml) and cooled to room 
temperature. The resultant aqueous mixture was extracted with 
dichloromethane (3 x 600 ml), the combined extracts were washed with water 
(2 x 800 ml), dried (MgSC>4 ) and the solvent was removed in vacuo to yield 
crude pyrrole as a brown oil. Ether (150 ml) was added to triturate the 
impurities and these were removed by filtration. The solvent was removed in
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vacuo . Kugelrohr distillation (150°C, 0.2 mm Hg) yielded [254] as a colourless 
oil (12.67g, 57%); VmaxineatJ/crn-1 3047(s), 1713(s) ; 8 h  (250 MHz, CDC13) 
10.92(1H, br s, CCbH). 6.71 (2H, d, J=2.2 Hz, a-pyrrole protons), 6.22(2H, d, J=2.1 
Hz, P-pyrrole protons), 4.00(2H, t, J=6.9 Hz, C(4)H), 2.41(2H, t, J=6.9 Hz,C(2)H), 
2.14(2H, m, C(3)H); 8c  (CDCI3) 171.44,119.97,108.0,43.62,36.19, 36.11.
6,7-Dihydro-5H-indolizidin-8-one [255] (PPA cyclization). [254] (12.2g, 0.08 
moles) was added to vigorously stirred polyphosphoric acid (lOOg, 85%) at 
90°C over ca 5 min. The dark reaction mixture was stirred for a further 20 min 
and poured into ice cold water (600 ml). The aqueous layer was separated and 
extracted with diethyl ether (5 x 800 ml). The organic layers were combined 
and the solvent was removed in vacuo. The resultant dark yellow oil was 
taken up in dichloromethane (100  ml) and washed with aqueous sodium 
carbonate (100 ml), brine (100 ml), dried (MgSC>4) and the solvent removed in 
vacuo. Kugelrohr distillation (220°C, 0.2 mm Hg) yielded [255] as a colourless 
oil which crystallized (6.5g, 56%). mp 36°C; (Found C, 71.32; H, 6.72; N, 10.38%; 
C8H9NO requires C, 71.1; H, 6.71; N, 10.4%); vmax(soln, CH2Cl2)/cm-1 3053(w), 
2962(w), 1659(s); 8 >h  (250 MHz, CDCI3) 6.97(1H, m, C(3)H), 6.83(1H, m, C(l)H), 
6.21(1H, m, C(2)H), 4.08(2H, t, J=5.7 Hz, C(5)H), 2.54(2H, t, J=6.30 Hz,C(7)H), 
2.23(2H, m, C(6 )H); 8c (CDC13) 187.18,130.56,125.83, 113.78,110.20, 45.03, 36.04, 
23.43.
4-Pyrrol-l-ylbutyric acid methyl ester [256]. Dry HC1 gas was bubbled through a 
solution of [254] (3.06g, 0.02 moles) in dry methanol (150 ml) for three hours. 
The methanol was then removed in vacuo to yield a brown oil (3.22g). 
Purification by Kugelrohr distillation (130°C, 0.2 mm Hg) yielded [256] as a 
clear oil (0.27g, 8 %); v ^ n e& O /cm ^  1740(s); 8h  (250 MHz, CDCI3) 6.69(2H, d, 
J=2.3 Hz, a-pyrrole protons), 6.17(2H, d, J=2.3 Hz, (J-pyrrole protons), 4.23(2H, t, 
J=6.9 H?, C(4)H), 3.71(3H, s, CQ2CH3 ), 2.79-2.43(4H, m, 2 x CH2); 8c  (CDCI3)
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171.46, 120.46, 108.35, 51.84, 44.78, 36.28, 36.25. Further Kugelrohr distillation 
(220°C, 0.2 mm Hg) yielded [255] as a clear oil which later crystallized (1.43g, 
53%). Analytical data was identical to [255] produced by PPA cyclization
8-Oxo-5,6,7,8-tetrahydroindolizidine-5-carboxylic acid methyl ester [214] 
(TMSOTf cyclization). To a solution of [224] (0.5g, 2.22 x 10'^ moles) in 
dichloromethane (100 ml) at -78°C, was added trimethylsilyltrifluoromethane 
sulfonate (2.4 ml, 0.013 moles, 6  equiv) dropwise over 20 min. The solution 
was maintained at -78°C for 2 h then allowed to attain room temperature and 
left stirring for 72 h. Triethylamine (1 ml) was added to quench the reaction 
and left for 30 min. The solution was then washed with dilute HC1 (100 ml), 
saturated Na2CC>3 (100 ml) and water (100 ml), dried (MgS04) and evaporated 
in vacuo to yield a yellow oil. Column chromatography (1:1 EtOAc : pet ether, 
S i02) yielded [214] as a pale yellow oil (0 .20g, 50%); [a]“ +13.2°(c 1.04, CH2C12); 
VmaxineaO/cm-l 1735(s); 8h  (250 MHz, CDC13) 6.94(1H, dd, J=1.5,4.0 Hz, C(3)H), 
6.80(1H, dd, J=1.5, 2.6 Hz, C(l)H), 6.21(1H, dd, J=2.6, 4.0 Hz, C(2)H), 4.88(1H, m, 
C(5)H), 3.67(3H, s, C0 2CH3), 2.45(4H, m, 2 x CH2); 8c  (CDCI3) 185.94, 169.95, 
130.40,126.66,114.61,110.98,56.47,52.93, 33.06,26.20; m /e (NH3, CI+) 194(MH+) 
[Found, 194.372(MH+), CioHi2NC>3 requires 194.0814].
S-Oxo-S^^S-tetrahydroindolizidine-S-carboxylic acid ethyl ester [238] 
(TMSOTf cyclization). To a solution of [227] (0.83g, 3.28 x 10‘ 3 moles) in 
dichloromethane (150 ml) was added trimethylsilyltrifluoromethane 
sulfonate (7 ml, 0.036 moles, 10 equiv) dropwise over 20 min. The solution 
was maintained at -78°C for 2 h then allowed to attain room temperature and 
left stirring for 72 h. Triethylamine (2 ml) was added to quench the reaction 
and this left for 30 min. The solution was then washed with dilute HC1 (100 
ml), saturated Na2CC>3 (100 ml) and water (100 ml), dried (MgSOi) and 
evaporated in  va cu o  to yield a yellow oil. Column chromatography (Et20 ,
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S i0 2) yielded [238] as a pale yellow oil (0.087g, 13%) (Found C, 63.2; H, 6.1; N, 
6 .6 %; Ch H13N 0 3 requires C, 63.77; H, 6.28; N, 6.76%); [a]“  +11.4° (c 1.42, 
CH2C12 ); VmaxineatVcin-l 1740(s); 8h  (250 MHz, CDC13) 7.06(1H, dd, J=1.4, 4.0 
Hz, C(3)H), 6.88(1 H, dd, J=1.4, 2.6 Hz, C(l)H), 6.31 (1H, dd, J=2.6, 4.0 Hz, C(2)H), 
4.92(1 H, m, C(5)H), 4.24(2H, q, J=7 Hz, CC^Cl^CHs), 2.59-2.54(4H, m, 2 x CH2), 
1.26(3H, q, J=7 Hz, CO2CH2CH3); 5c  (CDCI3) 185.99,169.45,130.39,126.52,114.56, 
110.93, 62.13, 56.55, 33.04, 26.17, 14.03; m/e (NH3, CI+) 208(100), 106(29%); 
[Found 208.0974(MH+), Cn H14N 0 3 requires 208.329].
8-Oxo-5, 6,7,8-tetrahydroindolizidine-5-carboxylic acid methyl ester [214] (BBr3 
cyclization). To a solution of [224] (2.97g, 0.0166 moles) in dichloromethane 
(2 0 0  ml) was added boron tribromide (1.6  ml, 0.0182 moles, 1.1  equiv) 
dropwise over 5 min. The solution was stirred for 15 min and water (15 ml) 
and saturated Na2CC>3 (50 ml) were added to quench the reaction and left for 
10 min. The organic layer was then removed and the aqueous layer was 
extracted with dichloromethane (100 ml). The combined organic layers were 
then washed with water (100 ml), dried (MgS04) and evaporated in vacuo to 
yield [214] as a yellow oil. Column chromatography (Et20 ,  S i02) yielded a pale 
yellow oil (0.26g, 80%); [a]“ +22.8° (c 1.18, CH2C12). Other spectral features 
were in agreement with [214] produced by TMSOTf cyclization.
8-Oxo-5,6,7,8-tetrahydroindolizidine-5-carboxylic acid ethyl ester [238] (BBr3 
cyclization). To a solution of [227] (4.2g, 0.0166 moles) in dichloromethane (200 
ml) was added boron tribromide (1.6  ml, 0.0182 moles, 1.1 equiv) dropwise 
over 5 min. The solution was stirred for 15 min and water (15 ml) and 
saturated Na2C0 3  (50 ml) added to quench the reaction and this left for 10 
min. The organic layer was then removed and the aqueous layer was extracted 
with dichloromethane (100 ml). The combined organic layers were then 
washed with water (100 ml), dried (MgS04) and evaporated in vacuo to yield a
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yellow oil. Column chromatography (Et2 0 , Si0 2 ) yielded [238] as a pale yellow 
oil (3.06g, 89%); [a]“ +22.0° (c 1.23, CH2CI2 )• Other spectral features were in 
agreement with [238] produced by TMSOTf cyclization.
8-Oxo-5,6,7,8-tetrahydroindolizidine-5-carboxylic acid methyl ester [214] (HC1 
cyclization). Dry HC1 gas was bubbled through a solution of [224] (1.5g, 7.57 x 
10 ' 3 moles moles) in dry methanol (150 ml) for 3 h. The methanol was 
removed in vacuo to yield a brown oil (1.78g). The crude product was purified 
by column chromatography (EtOAc:Pet ether, 1:2, Si02) to yield [214] as a 
colourless oil (0.86g, 59%); [a]“ +12.0° (c 1.1, CH2C12). Other spectral features 
were in agreement with [214] produced by TMSOTf cyclization.
8-Oxo-5,6,7,8-tetrahydroindolizidine-5-carboxylic acid ethyl ester [238] (HC1 
cyclization). Dry HC1 gas was bubbled through a solution of [227] (1.018g, 4.02 x 
10 ' 3 moles) in dry ethanol (150 ml) for 3 h. The ethanol was removed in 
vacuo to yield a brown oil (2.54g). The crude product was purified by column 
chromatography (EtOAcPet ether, 1:2, Si02) to yield [238] as a colourless oil 
(0.2g, 24%). [a]„ +13.8° (c 1.22, CH2C12). Other spectral features were in 
agreement with [238] produced by TMSOTf cyclization.
8-Oxo-5,6,7,8-tetrahydroindolizidine-5-carboxylic acid methyl ester [214] 
(amberlyst A15 cyclization). To a solution of [225] (1.5g, 7.6 x 10*3 moles) in dry 
methanol (75 ml) was added Amberlyst 15 (1.25g). The A15 had previously 
been treated by washing with 1M HC1, and freeze-dried. The suspension was 
refluxed under nitrogen for 48 h, cooled and the resin was removed by 
filtration. The methanol was removed in vacuo to yield a brown oil (2.12g). 
The crude product was purified by column chromatography (Et2 0 , Si0 2 ) to 
yield [214] as a colourless oil (0.69g, 47%); [a]“ +14.2° (c 1.2, CH2C12). Other
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spectral features were in agreement with [214] produced by TMSOTf 
cyclization.
8-Oxo-5,6,7,8-tetrahydro-indolizidine-5-carboxylic acid methyl ester [214] 
(amberlyst A15 cyclization). To a solution of [224] (1.86g, 8.2 x 10' 3 moles) in 
dry methanol (75 ml) was added Amberlyst 15 (1.37g). The A15 had previously 
been treated by washing with 1M HC1, and freeze-dried. The suspension was 
refluxed under nitrogen for 48 h, cooled and the resin removed by filtration. 
The methanol was removed in vacuo to yield a brown oil (2.12g). The crude 
product was purified by column chromatography (Et2 0 , SiC>2) to yield [214] as a 
colourless oil (0.88g, 56%); [a ]“ +22.1° (c 1.3, CH2CI2). Other spectral features 
were in agreement with [214] produced by TMSOTf cyclization.
8-Oxo-5,6,7,8-tetrahydroindolizidine-5-carboxylic acid ethyl ester [238] 
(amberlyst A15 cyclization). To a solution of [227] (1.06g, 4.19 x 10*3 moles) in 
dry ethanol (75 ml) was added Amberlyst 15 (1.37g). The A15 had previously 
been treated by washing with 1M HC1, water and freeze-dried. The suspension 
was refluxed under nitrogen for 48 h, cooled and the resin removed by 
filtration. The ethanol was removed in vacuo to yield a brown oil (2.54g). The 
crude product was purified by column chromatography (Et2 0 , Si0 2 ) to yield 
[238] as a colourless oil (0.47g, 54%). [a]“ +21.4° (c 1.23, CH2CI2 ). Other spectral 
features were in agreement with [238] produced by TMSOTf cyclization.
8-Oxo-5,6,7,8-tetrahydroindolizidine-5-carboxylic acid methyl ester [214] (PPA 
cy cliza tio n ). [224] (2.0g, 8.8 x 10-3 moles) was added to refluxing 
polyphosphoric acid (20g). The solution was refluxed under nitrogen for 48 h, 
cooled and poured into water (100 ml). Dichloromethane (100 ml) was then 
added, the aqueous layer was separated and extracted with dichloromethane (2 
x 50 ml). The combined organic layers were then washed with dilute HC1 (200
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ml), water (200 ml) and brine (100 ml), dried (MgSC>4 ) and evaporated in 
vacuo  to yield a red oil. The crude product was purified by column 
chromatography (Et2 0 , SiC>2) to yield [214] as a colourless oil (0.29g, 24%); [a]“ 
+18.02° (c 2.1, CH2CI2). Other spectral features were in agreement with [214] 
produced by TMSOTf cyclization.
8-Oxo-5,6,7,8-tetrahydroindolizidine-5-carboxylic acid ethyl ester [238] (PPA 
cy c liza tio n ). [227] (1.99g, 7.87 x 10' 3 moles) was added to refluxing 
polyphosphoric acid (20g). The solution was refluxed under nitrogen for 48 h, 
cooled and poured into water (100 ml). Dichloromethane (100 ml) was then 
added, the aqueous layer was separated and extracted with dichloromethane (2 
x 50 ml). The combined organic layers were then washed with dilute HC1 (200 
ml), water (200 ml) and brine (100 ml), dried (MgSCXt) and evaporated in 
vacuo to yield [238] as a red oil. The crude product was purified by column 
chromatography (Et2 0 , SiC>2 ) to yield a colourless oil (0.29g, 18%); [a]“ +12.9° 
(c 1.26, CH2CI2). Other spectral features were in agreement with [238] produced 
by TMSOTf cyclization.
Hydrogenation of 6,7-Dihydro-5H-indolizidin-8-one [255]. A solution of [255] 
(200 mg, 1.48 x 10‘3 moles) in dry methanol (100 ml) containing H2SO4 (5 
drops), with catalyst (w/w with substrate either 5% Rh on alumina or 10% Pd 
on carbon) was hydrogenated at 55 psi for 18 h. The catalyst was removed with 
a celite pad and the solvent was removed in vacuo. Water (100 ml) was added 
to the residue and extracted with ether (2 x 100 ml). The aqueous layer was 
then extracted with dichloromethane (2  x 1 0 0  ml) and the combined 
dichloromethane fractions were dried (MgS04) and evaporated in vacuo to 
yield a pale yellow oil (182 mg, 87%) which upon purification (AI2O3, EtOAc) 
was found to be a mixture of three products (±)[261a], (±)[261b], (±>[262].
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R h/A l20 3, [261](170.6mg): [262](11.4mg)(15:l); Pd/C, [261 ](9.6m g): 
[262](172.4mg)(l:18).
(±) 9(eq)-Octahydroindolizidin-8-ol204 (±)I261a]; vmax(soln, C P^C ^/cm *1 
3528(m), 2712(w) cm’l; 5h  (400 MHz, CDC13) 3.36(1H, dq, J = 10.7, 4.4 Hz, 
C(8 )H), 3.04(1 H, dt, J = 2.2, 9.0 Hz, C(3)Heq), 2.87(1H, brs, OH) 2.13(1H, q, J = 9.0 
Hz, C(3)Hax), 2.10-1.46(10 H, m, ring protons), 1.21-1.14(1H, m,C(7)Hax); 5c  
(CDC13) 72.90, 70.26, 54.07, 51.67, 33.72, 28.17, 24.18, 20.57; m/e (NH3, CI+) 
142(MH+(100)), 124(28), 97(63), 84(60), 69(25).
(±) 9(ax)-Octahydroindolizidin-8-ol204 (±)[261b]; vmax(soln, CT^C^l/cm *1 
3520(m), 2710(w), cm4 ; 8h  (400 MHz, CDC13) 3.75(1H, brs, C(8 )H), 3.06-2.80(3H, 
m, C(5)Heq, C(9)H / C(3)Heq ), 2.80-2.60(lH, brs, OH), 2.04(1H, q, J = 9 Hz, 
C(3)Hax), 2 .0 -1 .6(7H, m, ring protons), 1.48-1.40(1H, m, C(5)Hax)/ 1.32(1H, tq, 
J=2.69,13.3 Hz, C(7)Hax; 5 c  (CDC13) 67.24, 65.48, 54.34, 52.78, 31.44, 24.89, 20.74, 
19.65. (mass spectral data is not reported due to difficulties in obtaining a 
sample uncontaminated with the other diastereoisomer.)
(±) Octahydroindolizidine (±)[262]; Vmax(soln, C ^ C kl/ cm -1 2780(m), 2700(w), 
2600(m) cm*1; 8h  (250 MHz, CDC13) 3.0-2.8(2H, m, C(3)Heq, C(5)Heq), 2.08(1H, 
q, J=8.9 Hz, C(3)Hax), 1.98(1H, dt, J=11.2, 3.4 Hz, C(5)Hax) 1.85-0.92(11H, m, ring 
protons); 8c  (CDC13) 64.19,54.11,52.90, 30.93,30.33,25.35,24.38,20.46.
(5S,8S,9R)-8-Hydroxyoctahydroindolizidine-5-carboxylic acid methyl ester 
[215]. A solution of [214] (500 mg, 1.15 x 10-3 moles) in dry methanol (100 ml) 
with 5% Rh on alumina (w/w with substrate) was hydrogenated at 55 psi for 8 
h. The catalyst was removed with a celite pad and the solvent was removed in 
vacuo. Water (100 ml) was added to the residue and the solution was extracted 
with diethyl ether (2 x 100 ml). The aqueous layer was then extracted with
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dichloromethane (2  x 100  ml) and the combined dichloromethane fractions 
were dried (MgSO,}) and evaporated in vacuo to yield [215] as a pale yellow oil 
as the single pure product (420 mg, 87%); [a]“ -91.4 (c 1.34, CH 2CI2 ); 
VmaxineatVcnr1 3526(m), 2807(s), 2734(s), 2712(w), 1741(s) cm*1; 8r  (250 MHz, 
CDCI3) 3.77(1H, brs, C(8 )H), 3.68(3H, s, CO2CH3 ), 3.16(1H, dt, J = 2.6, 8.7 Hz, 
C(3)Heq), 2.79(1H, dd, J = 3.8, 9.7 Hz, C(5)H), 2.57(1H, brs, OH), 2.1-1.6(9H, m, 
ring protons), 1.14(1H, tq, J=1.6, 3.1, 8.55 Hz, H(7)ax); 8c  (CDCI3) 172.44, 66.56, 
64.69, 52.18, 51.70, 31.21, 24.58, 23.78(2), 20.27; m/e (NH3, CI+) 200(100), 185(53), 
96(13); [Found, 200.165(MH+), C10H18NO3 requires 200.1282],
(5S,9R)-Octahydroindolizidine-5-carboxylic acid methyl ester [263]. A solution 
of [214] (670 mg, 3.96 x 10' 3 moles) in dry methanol (100 ml) containing H2SO4 
(6  drops) with 10% Pd on C (w/w with substrate) was hydrogenated at 45 psi 
for 14 h. The catalyst was removed with a celite pad and the solvent was 
removed in vacuo. Water (100 ml) was added to the residue, the solution 
basified (Na2CC>3) and extracted with diethyl ether(2 x 100 ml). The aqueous 
layer was then extracted with dichloromethane (2  x 100  ml) and the combined 
dichloromethane fractions were dried (MgS0 4 ) and evaporated in vacuo to 
yield [263] as a pale yellow oil as the single pure product(520 mg, 85%); [a]“ 
-109.4°(c = 1.592, CHCI3 ); vmax(neat)/crn-l 2980(s), 2734(s), 2712(w), 1749(s) cnr 
1; 8 h  (250 MHz, CDCI3) 3.68(3H, s, CO2CH3), 3.14(1H, dt, J = 2.6,8.1 Hz, C(3)Heq), 
2.80(1H, dd, J = 3.8,9.7 Hz, C(5)H), 1.86(1H, q, J = 8.7 Hz, C(3)Hax), 1.79-1.32(11H, 
m, ring protons); 8c  (CDCI3) 171.2,67.12, 63.87, 60.25,51.93,29.80, 29.50, 20.26(2), 
14.08; m/e (NH3, CI+) 184 (MH+, 100), 124(41); [Found, 184.147(MH+), 
C10H18NO2 requires 184.133].
(5S,8S,9R)-8-Hydroxyoctahydroindolizidine-5-carboxylic acid ethyl ester [264].
A solution of [238] (240 mg, 1.15 x 10-3 moles) in dry methanol (100 ml) with 
5% Rh on alumina (w/w with substrate) was hydrogenated at 55 psi for 8  h.
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The catalyst was removed with a celite pad and the solvent was removed in 
vacuo. Water (100 ml) was added to the residue and extracted with diethyl 
ether (2 x 100 ml). The aqueous layer was then extracted with 
dichloromethane (2 x 100  ml) and the combined dichloromethane fractions 
were dried (MgSQi) and evaporated in vacuo to yield [264] as a pale yellow oil 
as the single pure product (210 mg, 87%); [a]“ -90.7 (c 1.6, CH2CI2 ); 
Vmax(neat)/cm-1 3522(m), 2980(s), 2734(s), 2712(w), 1753(s) cm'1; 5h  (250 MHz, 
CDCI3) 4.15(2H, q, J = 7.25 Hz, C 02CH2CH3),3.78(1H, brs, C(8 )H), 3.19(1H, dt, J = 
2.6, 8.1 Hz, C(3)Heq), 2.78(1H, dd, J = 3.8, 9.8 Hz, C(5)H), 2.64(1H, brs, OH), 2.1- 
1.4(10H, m, ring protons), 1.24(3H, t, J = 6.97 Hz, CO2CH2CH3 ); 5 c  (CDCI3) 
172.67, 66.72, 64.75, 60.56, 57.10, 31.27, 24.61, 23.79(2), 20.41, 14.09; m/e (NH3, 
CI+) 214(37), 140(100), 82(22); [Found 214.1443(MH+), C11H20NO 3 requires 
214.1438].
(5S,9R)-Octahydroindolizidine-5-carboxylic acid ethyl ester [265]. A solution of 
[238] (780 mg, 3.96 x 10"3 moles) in dry methanol (100 ml) with 10% Pd on C 
(w/w with substrate) was hydrogenated at 45 psi for 14 h. The catalyst was 
removed with a celite pad and the solvent was removed in vacuo. Water (100 
ml) was added to the residue, the solution basified (Na2CC>3) and extracted 
with diethyl ether (2 x 100 ml). The aqueous layer was then extracted with 
dichloromethane (2  x 100  ml) and the combined dichloromethane fractions 
were dried (MgSC^) and evaporated in vacuo to yield [265] as a pale yellow oil 
as the single pure product (665 mg, 85%); [a]“ -80.2°(c = 1.592, CHCI3 ); 
vmax(neat)/cm-i 2980(s), 2734(s), 2712(w), 1745(s) cm'1; 5h  (250 MHz, CDCI3) 
4.13(2H, q, J = 7.2 Hz, CO2CH2CH3), 3.14(1H, dt, J = 2.6,8.1 Hz, C(3)Heq), 2.65(1H, 
dd, J = 3.8, 9.8 Hz, C(5)H), 1.86(1H, q, J = 8.1 Hz, C(3)tL,x), 1.83-1.K11H, m, ring 
protons), 1.18(3H, t, J = 7.2 Hz, CO2CH2CH3 ); 5 c  (CDCI3) 173.03, 67.14, 63.92, 
60.35, 51.93, 29.84, 29.54, 24.06(2), 20.27,14.08; m/e (NH3, CI+) 198(100), 124(41); 
[Found, 198.1494(MH+), C11H20NO2 requires 198.1489].
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(5S,9R)-8-Oxooctahydroindolizidine-5-carboxylic acid methyl ester [281]. To a
solution of oxalyl chloride (140 mg, 1.1 x 10"3 moles, 1.1  equiv) in 
dichloromethane (10 ml) at -78°C under nitrogen, was added dimethyl 
sulfoxide (200 mg, 2.4 x 10'3 moles, 2.4 equiv) in dichloromethane (5 ml) over 
5 min. Stirring was continued at -78°C for 10 min followed by the addition of 
[215] (2 0 0  mg, 1 x 10'3 moles, 1 equiv) dissolved in dichloromethane (10 ml). 
The reaction mixture was stirred for 15 min, then triethylamine (0.7 ml, 5 x 
10'2 moles) was added over 5 min with stirring. The cooling bath was 
removed and water (30 ml) was added at room temperature. Stirring was 
continued for 10 min and the organic layer was separated. The aqueous phase 
was re-extracted with dichloromethane (2 0  ml), the organic layers were 
combined and washed succesively with dilute HC1 (20 ml), water (20 ml), 
dilute sodium carbonate (20 ml) and water (20 ml). The organic layers were 
then dried (MgS0 4 ) and evaporated to dryness to give almost colourless crude 
ketone [281] which was used without further purification (110 mg, 55%); 8h  
(CDCI3 , 250 MHz) 3.74 (3H, s, C0 2 CH3 ), 3.29 (1H, dd, J=9.9, 3.8 Hz, C(5)H), 3.21 
(1H, dt, J =8 .1, 2.6 Hz, C(3)Heq), 2.77 (1H, t, J=8.1 Hz, C(3)HaX), 2.58-1.6 (9H, m, 
ring protons); 8c  (CDCI3 ) 205.48, 172.30, 69.71, 64.31, 52.42, 37.91, 28.75, 22.68, 
20.45,17.21.
5,6,7,8-Tetrahydroindolizidine-5-carboxylic acid methyl ester [282]. A dry 
distillation kit, under nitrogen, was charged with [214] (200mg, 1 x 10*3 moles, 
1 equiv) and dichloromethane (20 ml). This was heated to reflux and borane- 
dimethyl sulfide (0.38 ml, 5 x 10'3 moles, 5 equiv) was added over 5 min. 
Reflux was continued until ca 5 ml of dimethyl sulfide/dichloromethane had 
distilled over, (accumulation of dimethyl sulfide seems to be detrimental to 
the yield of the reaction). The reaction mixture was cooled to room 
temperature and saturated sodium carbonate (10 ml) and dichloromethane
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(10 ml) were added. When the frothing had subsided, the quenched mixture 
was extracted with dichloromethane (2 x20  ml), the organic layer was 
removed, washed with water (20 ml) and brine (20 ml). The organic phase was 
dried (MgSC>4 ) and the solvent was removed in vacuo to yield a yellow oil 
(190 mg). Purification by chromatography (50% EtOAcrPet ether;SiC>2 ) gave 
[282] (160 mg, 80%); vmax (soln, CHCl3 )/cnrl 2955(s) 2241(m) 1751(s)cm-l; 8 h  
(250 MHz, CDCI3 ) 6.51 (1H, m, C(3)H), 6.16 (1H, m, C(l)H), 5.88 (1H, m, C(2)H), 
4.76(1H, m, C(5)H), 3.75(3H, s, CCbM e). 2.79(2H, m, C(8 )CH2 ), 2.25(2H, m, 
C(6 )CH9 ). 1.82(2H, m, C(7 )CH2 ); 8c  (CDCI3 ) 172.22,128.85,119.13,108.22,104.39, 
57.11, 52.51, 27.24, 23.05,18.82; m/z (Cl, NH3 ) 180(MH+, 80%), 162(74), 120(100), 
91(69).
5.3 Experimental details for Chapter 3.
(5S,9R)-(Octahydroindolizidine-5-yl)methanol [314]. To LiAlPLi (64 mg, 1.7 x
10‘3 moles, 1.5 equiv) under nitrogen was added dry THF (10 ml) at 0°C, and 
the suspension was left for 10 min. To this suspension was added [265] (240 
mg, 1.13 x 10-3 moles) in THF (5 ml). After 1.5 h at 5-10°C, KOH (50 mg) and 
water (5 ml) were added and the solution was left for 15 min. The aqueous 
solution was then decanted and extracted with diethyl ether (3 x 20 ml). The 
combined organic layers were then washed with brine (20 ml), dried (MgSC>4) 
and the solvent removed in vacuo to yield [314] as a colourless oil (120 mg, 
69%); [a ]“ -78.4 (c 1.08, CH2C12 ); vmax(neat)/crn-l 3387(m), 2718(s); 8 h  (250 
MHz, CD3OD) 3.61(1H, dd, J = 11.1,4.8 Hz, C(10)H), 3.38(1H, dd, J = 11.1,5.9 Hz 
C(IO)H'), 3.17(1H, dt, J = 8.4, 2.6 Hz, C(3)Heq), 2.03(1H, q, J = 8.4 Hz, C(3)Hax), 
2.05-1.07(13H, m, ring protons); 8c  (CDCI3) 65.21, 65.03,64.25, 51.13, 29.73, 29.15,
28.00, 23.66, 19.89; m/e (NH3, CI+) 156(100), 124(13); [Found, 156.1388(MH+), 
C9H18NO requires 156.1384],
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(5S,9R)-(Octahydroindolizidine-5-yl)methyl-0-p-toluene sulfonate [315]. To a 
solution of [314](90 mg, 5.77 x 10-4 moles) in dry CH2CI2 (10 ml) under an 
atmosphere of nitrogen at -78°C was added nBuLi (0.27 ml, 6.92 x 10‘4 moles,
I. 2 equiv). This solution was left for 10 min in which time it was allowed to 
warm to -20°C. Tosyl chloride (217mg, 1.15 x 10-3 moles, 2.0 equiv) was added 
portionwise and the reaction mixture was allowed to attain room 
temperature overnight. Water (10 ml) was then added to the solution, the 
aqueous layer was separated and extracted with CH2CI2  (2  x 1 0  ml). The 
combined organic layers were then dried (MgSC>4 ) and the solvent was 
removed in vacuo to yield an off white solid (200mg). Purification by column 
chromatography (1:1 EtOAc:Pet ether, Si0 2 ) yielded [315] as a colourless oil 
(36mg, 26%); [a]“ +20.4 (c 1.73, CH2C12 ); vmax(neat) 2718(s); 8 h  (250 MHz, 
CD3OD) 7.69(2H, d, J=7.8 Hz, ArH), 7.10(2H, d, J=7.8Hz, ArH),3.61(lH, dd, J =
I I .  1,4.9 Hz, C(10)H), 3.42(1 H, dd, J = 11.1,5.9 Hz C(IO)H'), 3.17(1H, dt, J = 8.4,2.6 
Hz, C(3)Heq), 2.45(3H, s, A1CH3), 2.03(1H, q, J = 8.4 Hz, C(3)ax), 2.05-l.ll(12H, m, 
ring protons); 8c  (CDCI3) 147.0, 139.86, 129.59, 127.02, 65.21, 65.03, 64.25, 52.10,
51.13,29.73,29.15,28.00,23.66,19.89.
Reaction of (5S,9RM octahydroindolizidine-5-yl)-m ethyl-0-p-toluene 
sulfonate [315] with lithiocuprates, (general procedure). To a suspension of 
copper (I)-iodide (4 equiv) in dry Et2 0  (20 ml) under an atmosphere of 
nitrogen at -20°C was added a solution of alkyl lithium in Et2 0  (8  equiv) 
portionwise to give a dark yellow suspension after half the addition and a 
black solution after the addition was complete. This solution was transfered 
by cannular into a solution of [315] (1 equiv) in dry THF (5 ml), under an 
atmosphere of nitrogen at -20°C. The solution was left at -20°C for 8  h and 
then left to attain room temperature overnight. The reaction mixture was 
quenched with saturated aqueous NH4CI (10 ml) and extracted with Et2 0  (2 x
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10 ml). The combined organic layers were then dried (MgS04) and the solvent 
removed in vacuo to yield only unreacted starting material.
Reaction of (5S,9R)-(octahydroindolizidine-5-yl)methyl-0-p-toluene sulfonate 
[315] with Grignard reagents, (general procedure). To a solution of [315] (1 
equiv) in dry THF (10 ml) under an atmosphere of nitrogen, at -20°C was 
added a commercially available solution of the Grignard reagent in Et2 0  (4 
equiv) over 10 min. The solution was maintained at -20°C for 5 h before being 
allowed to attain room temperature overnight. The reaction mixture was 
then quenched with water (5 ml) and extracted with Et2 0  (2 x 10 ml). The 
organic extracts were combined, dried (MgSC>4) and the solvent removed in 
vacuo to yield only unreacted starting material.
8-Oxo-5,6,7,8-tetrahydroindolizidine-5-carboxylic acid methyl ester [214]. A
solution of 8-oxo-5,6,7,8-tetrahydroindolizidine-5-carboxylic acid ethyl ester 
[238] (100 mg, 4.83X10"4 moles) in methanol (5 ml) containing H2SO4 (6  drops) 
was refluxed for 3 h. The solution was then cooled to room temperature and 
diluted with water (20  ml). This solution was then extracted with CH2CI2 (3 x 
10 ml), the organic layers dried (MgSQ|) and the solvent was removed in 
vacuo to yield a pale brown oil (134 mg). The crude product was then purified 
by column chromatography (Et2 0 , SiC>2) to yield material identical to [214] 
(6 8 mg, 74%).
(5S,8S,9R)-5-(methoxycarbonyl)octahydroindolizidine-8-yl-0-p-toluene 
sulfonate [308]. To a suspension of sodium hydride (60% dispersion, 42 mg, 
1.06 x 10'3moles, 1.5 eq) in THF (10 ml) was added a solution of (5S,8S,9R)-5- 
methoxycarbonyl-8 -hydroxyindolizidine [215](160 mg) in THF (1 ml) at -78°C. 
After 10 min tosyl chloride (200 mg, 1.06 x 10‘3moles, 1.5 eq) was added 
portiohwise and the resulting solution was left stirring to attain room
167
temperature for 12 h. Water (5 ml) was added carefully and the resulting 
solution was extracted with dichloromethane (3 x 10 ml). The organic layers 
were combined, dried (MgSC>4 ) and the solvent was removed in vacuo to 
yield a brown oil (140 mg). Purification by column chromatography (50% ethyl 
acetate : pet ether ; S i02) gave [308] as a colourless oil (74mg, 20%); 
Vmax(neat)2718(s); 8 r  (250 MHz, CDC13) 7.69(2H, d, J=7.8 Hz, ArH), 7.10(2H, d, 
J=7.8Hz, ArH), 3.86(1H, br s, C(8 )H), 3.690H, s, CCbMe). 3.35(1H, dist t, J=8.7 Hz, 
C(3)Heq), 3.12(1H, dd, J=3.7, 9.8 Hz, C(5)H), 2.45(3H, s, ArCF^), 2.21(1H, m, 
C(9)H), 2.05-1.67(9H, m, ring protons); 8c  (CDCI3) 171.84, 146.74,139.73, 129.57, 
126.98,67.37, 64.37,52.18, 52.05,30.94,24.29,23.31(x2), 21.68, 20.13.
(5S,8S,9R)-8-[(l,l-dimethylethyl)dimethylsiloxy]octahydroindolizidine-5- 
carboxylic acid methyl ester [311] To a solution of [215] (60 mg, 3.02 x 10' 4 
moles) in DMF (1 ml) containing imidazole (21 mg, 3.3 x 10-4 moles, 1.1 equiv) 
at 0°C was added tBDMSCl (50 mg, 3.3 x 10"4 moles, 1.1 equiv) portionwise 
over 10 min. The solution was then heated under reflux for 4 h, cooled and 
diluted with water (1 0  ml), and CH2CI2 (10 ml) was added. The aqueous layer 
was then separated and extracted with CH2CI2 (2  x 10  ml). The combined 
organic layers were then dried (MgSC>4 ) and the solvent was removed in 
vacuo to yield a pale brown oil (70 mg). Purification by chromatography(50% 
ethyl acetate:pet ether;SiC>2 ) gave [311] as a colourless oil (1 0  mg, 1 1 %); [a]” - 
24.7(c 1.64, CH2C12 ); vmax(neat) 2718(s); 8 h  (250 MHz, CDCI3) 3.91(1H, br s, 
C(8 )H), 3.72(3H, s, CCbM e). 3.21(1H, dist t, J=6.7 Hz, C(3)Heq), 2.76(1H, dd, 
J=11.2, 2.9 Hz, C(5)H), 2.1-1.4(9H, m, ring protons), 1.25(1H, m, C(7)Heq), 0.905, 
(9H, s, ‘Bu group), 0.05(6H, s, Si(CH3)2).
(5S,8S,9R)-8-0-Methoxymethyloctahydroindolizidine-5-carboxylic acid methyl 
ester [312]. To a solution of [215] (90 mg, 4.5 x 10-4 moles) in DMF (1 ml) 
containing (iPr^NEt (1 ml) at 0°C was added methoxymethyl chloride (0.05
168
ml, 6.78 x 10"4 moles, 1.5 equiv) over 10 min. The solution was left at 0°C for 1 
h and then allowed to attain room temperature overnight. Water (10 ml), and 
CH2CI2 (10 ml) were then added. The aqueous layer was then separated and 
extracted with CH2CI2 (2 x 10  ml). The combined organic layers were then 
dried (MgSC>4 ) and the solvent was removed in vacuo to yield a pale brown 
oil. Purification by chromatography (80% EtOAc:20% Pet ether; SiC>2 ) gave 
[312] as a colourless oil (55mg, 30%); 8h  (250 MHz, CDCI3 ) 4.77(1H, d, J=6.97 Hz, 
-O-CH2-O-), 4.62(1H, d, J=6.97 Hz, -O-CH2 -O-), 3.80(1H, br s, C(8 )H), 3.71(3H, s, 
CCbM e). 3.37(3H, s, OCH3), 3.22(1H, dist t, J=6.97 Hz, C(3)Hax) 2.78(1H, dd, 
J=11.47, 2.6 Hz, C(5)H), 2.1-1.6(10H, m, ring protons).
8-Oxa-2-aza-tricyclo-[5.2.2.0]-2,6-undecan-9-one [313]. To a suspension of 
sodium hydride (60% dispersion, 31 mg, 7.6 x lO^moles, 1.2 eq) in THF (5 ml) 
was added a solution of (5S,8S,9R)-5-ethoxycarbonyl-8-hydroxyindolizidine 
[264] (160 mg) in THF(1 ml) at 0°C. After 10 min, TMSC1 (0.1 ml,7.6 x 10" 
4moles, 1.2  eq) was added and the resulting solution was left stirring to attain 
room temperature for 12 h. Water (5 ml) was added carefully and the 
resulting solution was extracted with dichloromethane (3 x 10 ml). The 
organic layers were combined, dried (MgSCU) and the solvent was removed in 
vacuo to yield a brown oil (140 mg). Purification by column chromatography 
(Et2 0 , AI2O3) yielded a white solid (50 mg, 39%); [a]“ +6.77°(c = 1.0, CHCI3 ); 
vmax(neat)/crn-i 2876(s), 1751(s) cm'1; 8 h  (400 MHz, CDCI3) 4.57(1H, s, C(8 )H), 
3.34(1H, m, C(5)tD, 3.27(1H, t, J = 8  Hz, C(9)H), 3.14(1H, t, J = 8  Hz, C(3)fcL»x), 
2.53(1 H, m, C(3)fieq), 2.10(1H, m, C(6 )HaX), 2.0-1.6(7H, m, ring protons); 8c  (100 
MHz, CDCI3 ) 173.34, 76.61, 60.69, 56.65, 53.37, 27.75, 24.81, 24.06, 23.50; m/e 
(NH3, CI+) 168(93), 140(46), 123(100), 110(45), 96(78), 83(38), 49(55), 41(35), 
[Found, 167.0946(MH+) C9H14NO2 requires 168.1021].
5.4 Experimental details for Chapter 4.
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AM3-[Acetyl-(4-acetylaminobutyl)amino]propyl)acetamide205 [380]. To a
solution of N-l-(3-amino-propyl)-l,4-diaminobutane [363] (l.Olg, 6.9 x 10‘3 
moles) in toluene (20 ml) at 0°C under nitrogen, was added acetic anhydride 
(6.6  ml, 6.9 x 1 0 '^ moles) over 30 min. The solution was left overnight and the 
solvent and excess acetic anhydride were removed in vacuo to yield a pale 
yellow oil. Purification by column chromatography (MeOH : CH2CI2, 1 : 10, 
SiC>2) yielded [380] as a colourless oil (1.66g, 8 8 %); 8 *H (400 MHz, CD3OD), [H = 
major isomer, H' = minor isomer] 3.41 (4H, m, H, H'(3)), 3.38(4H, m, H, H'(5)), 
3.25(4H, m, H’(l,7)), 3.21(4H, m, H (l,7)), 2.15(3H, s, N(4)Ac), 2.14(3H, s, 
N'(4)Ac), 2.00(3H, s, N(l)Ac), 1.99(3H, s, N(8 )Ac), 1.85(2H, m, H'(2)H), 1.78(2H, 
m, H(2)), 1.67(4H, m, H(6,7)), 1.56, (4H, m, H'(6,7); 8c  (CD3OD) 171.1,170.5, 48.4,
47.0, 45.3, 42.5, 38.6, 37.0, 36.1, 29.0, 27.7, 27.4, 27.1, 26.5, 25.8, 24.8, 23.3, 23.2, 23.0, 
21.4; m/e (NH3, CI+) 272(74%).
Tris(benzyloxycarbonyl)-N-l-(3-aminopropyl)butane-l,4-diamine186 [381]. To a 
solution of N-l-(3-aminopropyl)-l,4-diaminobutane [363](0.82g, 5.7 x 10‘ 3 
moles) in saturated aqueous Na2CC>3 (20 ml) at 0°C under nitrogen was added 
benzyl chloroformate (2.7 ml, 0.019 moles) over 30 min. The solution was left 
overnight. The resulting biphasic system was then extracted with ethyl acetate 
(3 x 20 ml) and the organic layers were then combined, dried with MgSC>4 and 
the solvent removed in vacuo to yield a pale yellow oil. Purification by 
column chromatography (MeOH : CH2CI2 , 1 : 10, Si0 2 ) yielded [381] as a pale 
yellow oil (2.18g, 70%); 8 >H (400 MHz, CDCI3 ); 7.21(15H, m, N(l,4,8)Ar), 
4.97(2H, s, N(4)CH2), 4.94(4H, s, N(1,8 )CH2 ), 3.19(4H, m, C(1,3 )CH2 ), 2.99((4H, 
m, C(5,8)CH2), 1.60(2H, qn, J = 6.9 Hz, C(2 )CH2), 1.37(4H, m, C(6,7)CH2); 8c  
(CD3OD) 173.46, 173.35, 173.25, 173.06, 49.69, 47.62, 46.51, 44.59, 40.38, 40.10, 
39.95, 38.15, 37.90, 29.42, 28.32, 27.57, 27.51, 26.96, 25.82, 22.50, 22.46, 22.42, 21.29, 
21.25; m/e (NH3, CI+) 548(MH+, 74%).
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AM4-Aminobutyl)acetamide185 [379]. To a solution of butane-1,4-diamine 
[365](5g, 0.057 moles) in glacial acetic acid (35 ml) at 60°C was added a mixture 
of acetic anhydride (4.5 ml, 0.048 moles) and glacial acetic acid (5 ml) over ca 3 
h. The solution was left overnight and excess acetic anhydride and the solvent 
were removed in vacuo. The residue was dissolved in hot water (40 ml), 
cooled to 0°C and adjusted to pH < 1 with 6M HC1 (10 ml). After evaporation 
to dryness in vacuo the resulting white solid was extracted with hot propan-2 - 
ol (4 x 20 ml). The combined extracts were concentrated in vacuo and cooled 
to -10°C. The resulting crystals were collected and recrystallised from propan- 
2-ol yielding white crystals of [379] (0.85g, 12%); mp 137-140°C (lit mp 136- 
139°C); 8 'h  (250 MHz, CD3OD) 4.37(2H, t, J=6.4 Hz, Q^NHAc), 2.99(2H, t, J=7.6 
Hz CH2NH2), 1.99(3H, s, CH3 ), 1.56(4H, m, 2 x CH2); 8c  (CD3OD) 170.2,40.36, 
39.56, 27.36, 25.86, 22.60; m/e (NH3, CI+) 131(60%).
*
N, N’-Bis(benzyloxycarbonyl)butane-l,4-diam ine [378]. To a solution of 
butane-1,4-diamine [365](1.65g, 0.19 moles) in saturated Na2CC>3 (100 ml) at 0°C 
under nitrogen was added benzyl chloroformate (7 ml, 0.4 moles) over 30 
min. The reaction mixture was left overnight and water (20 ml) was added. 
The pH of the solution was adjusted to 7 producing a white solid which was 
collected and recrystallised from methanol yielding colourless crystals of [378] 
(4.39g, 6 6 %); mp 137-139°C; 8 'h  (250 MHz, CDCI3 ) 7.34(10H, m, Ar), 5.08(4H, s, 
CH2 -Ar), 4.88(2H, brs, Nil), 3.18(4H, m, NH-Cfch), 1.51(4H, m, NH-CH2CH2 ); 
8c  (CDCI3) 173.78, 156.19,136.35,128.32, 127.91, 66.46,40.44, 27.03; m/e (NH3/ 
CI+) 357(72%); m/e (NH3, CI+) [Found, 357.1816(MH+) C20H27N2O4 requires 
357.1808].
Lypholysed Enzymes (general procedure). To the enzyme (100 mg) was added 
buffer (10ml) and the resulting solution stirred at room temperature for 3 h. 
The solutioh was then frozen in liquid nitrogen and placed on a freeze-dryer
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over night or until a dry powder was obtained. This was then used in the 
procedures as 'biocatalyst'. Pre-lypholysed enzyme was used in all procedures 
to allow for direct comparison.
Enzymatic hydrolyses (general procedures).
Aqueous buffered solutions.
To substrate (50 mg) in solvent (10 ml) was added biocatalyst (10 mg). See 
Tables 4, 5. The reaction was monitored by TLC over a period of 4-10 days, 
using MeOH:CH2C l2 (1:3) as the solvent system and visualising the 
compounds with either iodine vapour or ninhydrin. Samples were taken at 
intervals and partitioned between water and ethyl acetate and both layers 
analysed by TLC.
Co-solvent systems.
To substrate (50 mg) in solvent (10 ml) was added biocatalyst (10 mg). See 
Tables 4, 5. The reaction was monitored by TLC over a period of 4-10 days, 
using MeOH:CH2C l2 (1:3) as the solvent system and visualising the 
compounds with either iodine vapour or ninhydrin. Samples were taken at 
intervals and partitioned between water and ethyl acetate and both layers 
analysed by TLC.
Low Water systems.
To substrate (50 mg) in solvent (10 ml) was added biocatalyst (10 mg). See 
Tables 4, 5. The reaction was monitored by TLC over a period of 4-10 days, 
using MeOH:CH2C l2 (1:3) as the solvent system and visualising the 
compounds with either iodine vapour or ninhydrin. Samples were taken at 
intervals and analysed directly by TLC.
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rBis-(phenyl acetyl)-butane-l,4-diamine [388]
To butane-1,4-diamine (l.llg , 0.013 moles) in toluene (20 ml) under nitrogen 
was added phenylacetyl chloride (3.68 ml, 0.03 moles) over 10 min. This was 
left for 36 hours. Removal of the solvent in vacuo yielded a white solid (3.97g) 
which was recrystallised from ethanol to give [388] as a white crystalline solid 
(2.94g, 72%); mp 178-180°C; VmaxinujoD/cnr1 3254(m), 1628(m); (Found C, 
73.72; H, 7.42; N, 8.73%; C20H24N2O2 requires C, 74.0; H, 7.46; N, 8 .6 %); 8^(250 
MHz, CDCI3 /CD4OD) 7.13(10H, m, Ar), 3.42(4H, s, CH->Ar). 3.06(4H, m, 
CH2NH), 1.32(4H, m, CH2CH2NH); 8c (CDC13) 173.88, 156.29, 136.44, 128.41,
128.00, 66.56,40.54, 27.12; m/e (NH3, CI+) 325(MH+, 100%), 223(18), 91(27).
Bis-(phenyl-isothiocyano)-butane-l,4-diamine [389]
To aqueous ethanol (100 ml, 4:5[v/v]) and butane-1,4-diamine (0.13g, 1.47 x 10" 
3) was added phenyl isothiocyanate (2.4 ml, 0.02 moles) under nitrogen. After 
2 0  min the resulting white solid was filtered off and washed with cold 
ethanol. This yielded [389] as a white crystalline solid (0.347g, 6 6 %); mp 156- 
158°C; vmax(nujol)/crn-l 3412(m), 1593(m), 1542(s); (Found C, 60.35; H, 6.16; N, 
15.42%; C18H 22N4S2 requires C, 60.30; H, 6.20; N, 15.6%); 81h  (250 MHz, 
(CD3)2CO) 7.37U0H, m, Ar), 3.65(4H, m, CtbNH), 3.16(2H, ArNH), 2.93(2H, 
NH), 1.68(4H, m, CH2CH2NH); 8c(C D 3)2CO) 182.27, 162.67, 129.83, 125.73, 
124.72,44.77, 27.07.
N-(5-aminopentyl)-3-aminopropionitrile201 [390]. Acrylonitrile (1.29 ml,
0.0253 moles) was added dropwise over 30 min to a solution of 1,4- 
diaminopentane (2.3 ml, 0.0196 moles) in a mixture of ethanol (30 ml) and 
water (20 ml) and left over night. The solution was heated over a steam bath 
for one hour, cooled, acidified to pH 3 with dilute HC1, and the solvent 
removed in vacuo to yield a white solid. Recrystallization from ethanol
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yielded [390 ] as white crystals of the HC1 salt (0.727g, 24%); mp 218-221°C (lit 
mp 216-219°C); vmax(nujol)/cm-l 3388(m), 2256(s); 6 ' h  (300 MHz, CD3OD) 
3.37(2H, dist t, J=7.2 Hz, CH2CN), 3.09(2H, dist t, J=7.2 Hz, NHCH2CH2CN), 
3.01(2H, dist t, J=7.2 Hz, CH2NH CH 2CH2CN), 2.98(2H, dist t, J=7.2 Hz, 
CH2NH2), 1.76(4H, m, C(7,8)CH2), 1.50(2H, m, C(6 )CH2); 8c  (CD3OD) 116.35, 
43.11, 39.17, 27.82, 26.69, 25.34, 23.14, 14.44; m/e (NH3, CI+) 156(MH+)[Found, 
156.1499 (MH+) C8Hi8N3 requires 156.1497].
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